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Sky-blue emitting bridged diiridium complexes: beneficial effects 
of intramolecular π–π stacking  
Daniel G. Congrave, Yu-Ting Hsu, Andrei S. Batsanov, Andrew Beeby and Martin R. Bryce
* 
The potential of intramolecular π–π interactions to influence the photophysical properties of diiridium 
complexes is an unexplored topic, and provides the motivation for the present study. A series of 
diarylhydrazide-bridged diiridium complexes functionalised with phenylpyridine (ppy)-based 
cyclometalating ligands is reported. It is shown by NMR studies in solution and single crystal X-ray 
analysis that intramolecular π–π interactions between the bridging and cyclometalating ligands rigidify 
the complexes leading to high luminescence quantum efficiencies in solution and in doped films. 
Fluorine substituents on the phenyl rings of the bridge promote the intramolecular π–π interactions. 
Notably, these non-covalent interactions are harnessed in the rational design and synthesis of the first 
examples of highly emissive sky-blue diiridium complexes featuring conjugated bridging ligands, for 
which they play a vital role in the structural and photophysical properties. Experimental results are 
supported by computational studies. 
 
Introduction 
 
Iridium(III) complexes possess rich metal-ligand based 
photochemistry, typically with high luminescence quantum 
efficiency (Φ) and short excited state lifetimes (τp). They are 
widely employed in applications1 such as photocatalysis,2 
biological labelling,3 sensing4 and as emissive dopants in 
phosphorescent organic light-emissive devices (PhOLEDs).5,6 
Their emission colour can be tuned across the entire visible 
spectrum by systematic variation of the ligands.7  
 Unlike their monometallic analogues, diiridium complexes 
are rarely studied for luminescence applications due to their 
generally low photoluminescence quantum yields (PLQYs) and 
limited colour range.8–17 However, there are examples where 
the favourable luminescent properties of monoiridium 
complexes are retained in diiridium complexes by the careful 
choice of conjugated bridging ligands.18–27 Moreover, bridging 
ligands offer scope for increased structural variation compared 
to monoiridium analogues, and allow tuning of the electronic 
communication between the iridium centres which may lead to 
interesting photophysical properties, such as improved spin-
orbit coupling effects,24,26 or dual emission. Diiridium 
complexes are known with efficient emission from red to 
green;18–26 however, we are not aware of any blue / sky-blue 
diiridium complexes featuring conjugated bridging ligands.28 
 Recently, we described diarylhydrazide-bridged diiridium 
complexes functionalised with phenylpyridine (ppy)-based 
cyclometalating ligands.22 These complexes are highly emissive 
in the green region when doped into rigid 
poly(methylmethacrylate) (PMMA) films, but are practically 
nonemissive in solution, presumably due to the flexibility of 
their non-ancillary bridging units which leads to non-radiative 
decay via intramolecular motion. An interesting structural 
feature was observed: the pendant aryl rings on the bridge 
engage in intramolecular face-to-face π–π stacking with the 
cyclometalating phenyl ligands in the solid state (complex 1, 
Figure 1). 
 Intramolecular π–π stacking between aryl and heteroaryl 
rings has been reported in a few specific monoiridium 
complexes (e.g. 2-6, Figure 1), particularly in charged 
derivatives.29–33 For example, in complex 2 intramolecular π–π 
stacking between a cyclometalating ligand and a pendant 
pentafluorophenyl group leads to an order of magnitude 
increase in solution PLQY, due to a reduction in the non-
radiative rate constant (knr).
31 Intramolecular π–π stacking in 
complex 3 leads to increased operational stability of light-
emitting electrochemical cells (LEECs).29 Nonetheless, the 
potential of intramolecular π–π interactions to influence the 
photophysical properties of diiridium complexes remains 
unexplored, and provides the motivation for the present study. 
 We now show that intramolecular π–π stacking can be 
exploited to rigidify diiridium complexes and to obtain high 
luminescence quantum efficiencies in solution and in doped 
films. We also present the first examples of highly emissive 
sky-blue diiridium complexes featuring conjugated bridging 
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ligands, for which the π–π interactions play an important role in the structural and photophysical properties. 
 
Figure 1. Representative iridium complexes which display intramolecular π–π stacking interactions, highlighted by the coloured rings. D = centroid–centroid 
distance determined by X-ray diffraction for the same-coloured rings. D
*
 = distance between the centroid of the bridge aryl ring and the plane of the 
cyclometalating ligand. 
Results and discussion 
 
Design, synthesis and characterisation 
The structural versatility of 1 and analogues22 provides an ideal 
opportunity to explore how intramolecular π–π interactions 
between the bridging and cyclometalating ligands can influence 
the photophysical properties of diiridium systems.  Benzene is 
well known to stack with hexafluorobenzene in a slipped face-
to-face configuration in the solid state.34–36  Complexes 7-9 
(Figure 2) with an increasing number of fluorine substituents on 
the phenyl rings of the bridge, were, therefore, designed with 
the aim of promoting intramolecular π–π interactions. Methoxy 
derivative 10 was also included based on calculations 
(discussed below) which predict the bridge of 10 to be non-
ancillary despite the highly fluorinated aryl rings (in contrast to 
8 and 9). The analogues 12 and 14, featuring CF3 substituents 
instead of perfluoroaryl rings, were studied as model 
compounds for which π–π interactions involving the bridge are 
not possible. For derivatives 11-15, the substituents on the 
pyridyl rings serve to enhance solubility. For 13-15 the 
difluorophenyl rings of the ppy ligands were chosen to blue 
shift the emission, based on monoiridium precedents.37,38   
 The diarylhydrazide bridges 17a–d (Figure 2) were 
synthesised (Scheme S1) by condensation of hydrazine 
monohydrate with the corresponding benzoyl chlorides, which 
were either commercially available or prepared from the 
corresponding benzoic acid (16a–d). The bridge units were 
heated in a 1:1 molar ratio with [Ir(ppy)2µ–Cl]2 in either 2-
ethoxyethanol (17a) or dry diglyme (17b-d) in the presence of 
K2CO3, to obtain the complexes 7–10 as diastereomeric 
mixtures (meso ɅΔ and rac ɅɅ/ ΔΔ) (Figure 2). In previous 
investigations, the diastereomers of analogous phenylpyridine-
functionalised diiridium systems were separated and minimal 
differences were observed in  the photophysical properties of 
the two diastereomers.21,22 Therefore, complexes 7-10 were 
characterised as diastereomeric mixtures. The complexes were 
unambiguously identified by 1H, 19F and 13C (where solubility 
allowed) NMR spectroscopy, MALDI–TOF mass spectrometry 
and elemental analysis. NMR peak assignments were aided by 
1H–1H COSY, 1H–1H NOESY, 1H–1H ROESY, 1H–13C HSQC, 
1H–13C HMBC and 19F–19F COSY 2D NMR experiments.  
 For complexes 7-10 the 19F NMR data are of particular 
interest. For the bis(difluorophenyl)hydrazide-bridged complex 
7, a single peak is observed in the 19F spectrum of the 
diastereomeric mixture (Figure S2), analogous to the spectrum 
of the free bridge (17a) (Figure S74). This indicates that the 19F 
environments are very similar for each diastereomer of 7 and 
that the bridging phenyl rings are freely rotating in solution on 
the NMR timescale.
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Figure 2. (Top) Structures for the diiridium complexes studied in this work. (Bottom) structures for the bridging and cyclometalating ligands. Complexes were 
studied as diastereomeric mixtures unless otherwise stated. * Complexes 14 and 15 were isolated as single diastereomers; their absolute configurations are 
unknown. 
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Figure 3. (Top) 
19
F NMR spectrum of the diastereomeric mixture of 9 (ca. 5:4 molar ratio of meso (ɅΔ) and rac (ɅɅ/ ΔΔ)). (Middle) 
19
F NMR spectrum of meso 
9 (Bottom) 
19
F–
19
F COSY NMR spectrum of meso 9 Chemical shifts are in ppm.
This contrasts with the data for the 
bis(pentafluorophenyl)hydrazide-bridged complex 9. The 
ligand 17c features 3 distinct environments in its 19F NMR 
spectrum as expected (Figure S80), whereas the 19F NMR 
spectrum of meso 9 features 5 well-resolved distinct 
environments (Figure 3, Figure S15) due to an apparent 
breakdown in symmetry, suggesting that rotation of the 
bridging pentafluorophenyl rings is restricted at room 
temperature in solution. This was confirmed when meso 9 was 
further studied by 19F–19F COSY NMR (Figure 3). This is 
because, although only ortho (3J ≈ 23 Hz) and para (5J ≈ 6 Hz) 
couplings are observed (in agreement with the multiplicities of 
the signals in the  1D spectrum), the data indicate that all 5 
fluorine environments are on the same ring. Meta (4J) 19F–19F 
coupling constants that are considerably smaller than those for 
ortho and para coupling (or even absent) have been commonly 
reported for heavily fluorinated aryl systems.39–43 It has been 
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suggested that this is because π-conjugation contributes 
significantly to 19F–19F coupling.39,43 
 We propose that this restriction of rotation is due to 
intramolecular π–π interactions. Steric restriction alone is 
unlikely to explain such well-resolved 19F NMR signals, 
considering that fluorine atoms exert similar steric effects as 
protons,44 and that the analogous difluoro complex 7 does not 
exhibit this effect. The 19F NMR spectra of complexes 8, 10, 
11, 13 and 15 also show this feature (Figures S5, S18, S24, 
S42, S51 and S68). These observations indicate that a bridge 
tetrafluorophenyl group is sufficient to promote strong 
intramolecular π–π interactions in solution, and that fluorine 
atoms on the cyclometalating phenyl rings of ppy ligands (13 
and 15) do not suppress them. 
 The bis(trifluoromethyl) bridge 1845 (Figure 2) was also 
investigated, as although it is strongly electron withdrawing 
like the perfluoroaryl bridge 17c,46 it cannot engage in 
intramolecular π–π stacking. Attempts to isolate a complex 
analogous to 9 by reacting the bridge 18 with [Ir(ppy)2µ–Cl]2 
were unsuccessful, due to its extremely poor solubility. (Mass 
spectra suggested the complex had formed). As an alternative, 
complex 12 was synthesised (Figure 2), which features 4-
mesityl-2-phenylpyridine (20) cyclometalating ligands. Mesityl 
groups are known to improve the solubility of cyclometalated 
iridium complexes while exerting minimal influence on their 
photophysical properties.47,48,49 Complex 12 was isolated as a 
diasteromerically pure meso sample (confirmed by X-ray 
diffraction, Figure S102) in 61% yield. No rac diastereomer 
was detected in the crude reaction mixture. This 
stereoselectivity is surprising as DFT calculations predict the 
rac diastereomer to be the more thermodynamically stable, as is 
usually the case for diiridium systems.21,22,50 Attempts to 
isomerise 12 thermally or photochemically were unsuccessful, 
as previously reported for other diiridium diastereomers.22  
 To allow a direct comparison with complex 12, complex 11 
(the mesityl-functionalised analogue of complex 9) (Figure 2), 
was also synthesised. Interestingly, the presence of mesityl 
groups leads to a larger difference in the solubilities of the 
diastereomers of 11 compared to 9, making them trivial to 
separate by column chromatography. However, the extremely 
poor solubility of meso 11 prevented its purification and so only 
rac 11 is studied here (stereochemistry confirmed by X-ray 
diffraction, Figure S101). It is noteworthy that meso 11 is less 
soluble than complex 9 despite the presence of mesityl groups, 
in contrast to the expectation based on previous reports.47,48,50 A 
tentative explanation is based on the symmetry of the 
complex.51  
 We have previously shown that colour tuning of the 
emission of diarylhydrazide-bridged diiridium complexes 
within the range max 520–490 nm can be achieved through 
functionalisation of either the bridge or cyclometallating phenyl 
rings with electron withdrawing groups.21,22 We reasoned, 
therefore, that simultaneous functionalisation of both moieties 
with electron withdrawing groups might afford blue / sky-blue 
diiridium complexes, which to date remain elusive.  
 Initial attempts to obtain diiridium complexes through a 
combination of 2-(2,4-difluorophenyl)pyridine (dfppy) or 2-
(2,4-difluorophenyl)-4-mesitylpyridine48 with the 
bis(pentafluorophenyl)/(trifluoromethyl) bridges 17c and 18 
(Figure 2) were unsuccessful due to the extremely poor 
solubility of the products.  
To enhance solubility the new dfppy derivative 21 (Figure 2) 
was synthesised (Scheme S1), wherein the mesityl group is 
replaced by a methylenecyclohexylether-functionalised xylyl 
group. The methylenecyclohexyl group provides the beneficial 
solubilising properties of a branched alkyl group while being 
achiral. Additionally, the xylyl spacer in 21 is a rigid non-
conjugated linker to limit the electronic influence of the 
electron-donating ether group.  
The ligand 22 (Figure 2) was also synthesised (Scheme S1) to 
investigate the effect of directly functionalising the pyridyl 
moiety with the methylenecyclohexyl group, which is expected 
to destabilise the lowest unoccupied molecular orbital (LUMO) 
and further blue shift emission.  
 As observed for 12, the bis(trifluoromethyl) bridge 18 
resulted in only a single diastereomer for complex 14 (Figure 
2). These two examples (12 and 14) suggest that 
bis(alkyl)hydrazide bridges afford diiridium complexes from 
racemic µ-dichloro dimers without the formation of 
diastereomeric mixtures. This is complementary to using  
enantiomerically pure dichloro-bridged dimers, as reported for 
other systems.49,52 
 Analogous to the mesityl-functionalised complex 11, the 
diastereomers rac 13 (stereochemistry confirmed by X-ray 
diffraction, Figure 4) and meso 13 were easily separated. The 
improved solubility imparted by the methylenecyclohexylether 
groups allowed both diastereomers to be fully characterised. 
Complex 15 was isolated as a single diastereomer: the absolute 
configuration is unknown, although it is probably the meso 
structure from inspection of the 1H NMR spectrum (Figure 
S66). A second diastereomer was observed by NMR but could 
not be isolated.  
 Thermal gravimetric analysis (TGA) shows that all the 
complexes 7-15 possess good thermal stability (Figures S144–
S153).  
 
X-Ray molecular structures 
Complexes 7 and 9–13 (Figures 4 and S97–S103) were 
characterised by single-crystal X-ray crystallography. Relevant 
parameters are listed in Table S1. All structures except 9 and 10 
contained disordered CH2Cl2 or CD2Cl2 of crystallisation.  
 In meso complexes 7, 9 and 12, the molecule possesses a 
crystallographic inversion centre (located at the midpoint of the 
N–N bond) relating the Ʌ and Δ metal centres. The rac 
complexes 10, 11 and 13 all crystallise in centrosymmetric 
space groups, thus each molecule is chiral (ɅɅ or ΔΔ) but the 
crystal is racemic. Two solvent-free polymorphs of 10 formed 
concomitantly; in α-10 the molecule lies on a crystallographic 
twofold axis while in β-10 (as in 11 and 13) it has no 
crystallographic symmetry. Each Ir atom has distorted 
octahedral coordination, involving one N and one O atom of the 
bridging hydrazide (OCNNCO) ligand, and two C^N 
cyclometalating ligands. As usual, the N atoms of the latter 
occupy axial positions, trans to one another.6,21 As reported 
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earlier,22 in meso complexes the hydrazide moiety is planar, 
while in rac isomers it is variously (by 7 to 24°) folded along 
the central N–N bond into two planar OCNN chelating 
fragments. The chelated Ir atoms can be coplanar with, or 
displaced from, their planes, but this does not affect the 
bonding pattern significantly. Each aryl substituent (A) at the 
bridging ligand is oriented approximately perpendicular to the 
hydrazide plane (thus precluding π-conjugation) and is stacked 
face-to-face (–) with a cyclometalating ligand, essentially 
with its phenyl ring (B) (Figures 4, S98–S101 and S103). This 
will shorten the effective conjugation length of the bridge and is 
beneficial for shifting emission towards the blue (see below).
 
Figure 4. X-ray molecular structures of meso 7, meso 9 and the core part of rac 13 (ΔΔ) with the xylyl substituents (R) omitted. Thermal ellipsoids are drawn 
at 50% probability level. H atoms are omitted for clarity. Vector D identifies intramolecular – interactions, meso 7 = 3.32 Å, meso 9 =3.24 Å, rac 13 = 3.27, 
3.19 Å. 
Generally, the stacking is closer and more parallel than in 
previously studied analogues with t-Bu and CF3-
substitutuents.21,22 To the best of our knowledge the systems 
studied here demonstrate the closest intramolecular – 
stacking reported for cyclometallated iridium complexes.22,29–33 
Comparison of the two polymorphs of 10 shows that different 
crystal packing has limited effect on the molecular 
conformation: in α-10 both rings A in a molecule are eclipsed 
with corresponding rings B, in β-10 one pair is nearly eclipsed 
and the other shows a quasi-graphitic overlap, ring A shifting 
towards the pyridyl ring of the C^N ligand. Interestingly, 
molecule 12, which lacks intramolecular stacking, is much less 
rigid – note the different conformations of two 
crystallographically non-equivalent molecules in the crystal 
(Figure S102). 
 
Computational study 
The optimised ground state S0 geometries for the complexes 
were calculated at the B3LYP/LANL2DZ:3-21G* level with 
the LANL2DZ pseudopotential for the iridium atoms and the 3-
21G* basis set for other atoms. This model chemistry was 
selected on the basis of previous computational studies,50,53 and 
ensures that these calculations are directly comparable with 
those reported for other diiridium complexes (such as complex 
1).21,22  For the complexes 13–15 the methylene 
cyclohexylether groups were substituted for methoxy groups to 
shorten calculation times. The geometries of the central 
hydrazide fragments are in good agreement with the XRD 
results discussed above.  
  Molecular orbital calculations provided insight into the 
localisation of the frontier molecular orbitals (FMOs). 
Reasonable agreement is observed between diastereomers for 
all complexes. The LUMOs are localised on the 
cyclometalating ligands, particularly the pyridyl moieties.21,22 
However, the localisation of the highest occupied molecular 
orbitals (HOMOs) varies more significantly between 
complexes: in some cases the HOMO contribution from the 
bridge centre is high (≥ 30%) (complexes 7, 10, 13 and 15) 
whereas in other cases the bridging ligands display ancillary 
character (complexes 8, 9, 11, 12 and 14). In this study, if the 
average HOMO contribution from the bridge centre for both 
diastereomers is <15%, the bridge is considered ancillary. This 
is summarised in Table S2. FMO plots for complexes 7, 9, 12 
and 13 are given in Figure 5 as representative examples. FMO 
plots for the other complexes are shown in Figures S126–S143.  
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Figure 5. Molecular orbital compositions for complexes rac 7, rac 9, meso 12 
and rac 13. The stated ratios represent the atom/ group contributions in 
percentages. 
 For complex 7 the HOMO has significant contributions 
from the Ir centres, the central component of the hydrazide 
bridge and the cyclometalating phenyl moieties, as in complex 
1.21,22 Further fluorination of the bridging aryl rings decreases 
the bridge HOMO contributions for complexes 8 (octafluoro) 
and 9 (decafluoro), so their HOMOs are primarily localised on 
the Ir centres and the cyclometalating phenyl groups, with their 
bridges expected to behave as ancillary ligands. As complex 10 
also features methoxy groups on the bridging unit, the effect of 
the electron withdrawing fluorine atoms is somewhat negated 
and the bridge still features notable HOMO localisation (32% 
average). Calculations predict very similar HOMO 
contributions for complexes 9 and 11, indicating that the 
mesityl groups have a negligible electronic effect, as 
expected.47,48 Lowering the π orbital energy of the 
cyclometalating ligands of complexes 13 and 15 through 
fluorination strongly shifts their HOMOs onto the bridging 
ligands so that the cyclometalating phenyl moieties have very 
low HOMO contributions (average of both diastereomers < 
15% for both complexes). There is negligible frontier orbital 
(HOMO or LUMO) contribution from the bridge aryl rings for 
all complexes featuring diarylhydrazide bridges, even upon 
perfluorination.  
 
Table 1. Oxidation potentials for the Ir
3+
/ Ir
4+ 
couples (E
ox
/ V) of compounds 7–15 referenced to FcH/ FcH
+ 
= 0.00 V.  
a Peak splitting between Eox(1) and Eox(2). b All reductions are electrochemically irreversible. c HOMO levels calculated from CV 
potentials by HOMO = –4.8 + (–E1/2
ox(1)), using ferrocene as the standard. d LUMO levels calculated from CV potentials by 
LUMO = –4.8 + (–Eredonset), using ferrocene as the standard. * Complexes 14 and 15 were isolated as single diastereomers; their 
absolute configurations are unknown. 
 
 For complexes 12 and 14 the bridging ligands are ancillary 
with negligible HOMO contributions (average of both 
diastereomers = 4% for both complexes), regardless of 
cyclometalating ligand fluorination. This is indicative of the 
shorter conjugation length of the bis(trifluoromethyl) bridge 18 
compared to the diarylhydrazide bridges studied here.  
 
Electrochemistry 
Complexes 7–15 (Figure 2) were studied by cyclic voltammetry 
(CV) to obtain their oxidation and reduction potentials. The 
data are listed in Table 1 and voltammograms are shown in 
Figures S104–S125. All complexes display two 
electrochemically reversible oxidation waves. These represent 
sequential oxidation of the iridium centres (Ir3+/ Ir4+ redox 
couples), which are electronically coupled via the conjugated 
bridging units and so are electrochemically inequivalent. For 
Complex Isomer 
E
ox(1) 
/V 
Epa/ Epc
 
 [E1/2 ] 
E
ox(2) 
/V 
Epa /Epc [E1/2] 
ΔE1/2 
/V
a E
red
onset
 
/V
b
 HOMO /eV
c
 LUMO /eV
d
 
7 mixture 0.53/ 0.31 [0.42] 0.77/ 0.58 [0.67] 0.25 −2.38 –5.22 –2.42 
8 mixture 0.56/ 0.49 [0.52] 0.81/ 0.74 [0.77] 0.25 −2.18 –5.32 –2.62 
9 mixture 0.61/ 0.52 [0.56] 0.85/ 0.76 [0.81] 0.25 −2.37 –5.36 –2.43 
10 mixture 0.54/ 0.46 [0.50] 0.80/ 0.72 [0.76] 0.26 −2.29 –5.30 –2.51 
11 rac 0.66/ 0.49 [0.58] 0.96/ 0.84 [0.90] 0.32 −2.37 –5.38 –2.43 
12 meso 0.67/ 0.57 [0.62] 0.85/ 0.72 [0.78] 0.16 −2.44 –5.42 –2.36 
13 
meso 0.96/ 0.90 [0.93] 1.36/ 1.21 [1.28] 0.35 −2.16 –5.73 –2.66 
rac 1.00/ 0.93 [0.97] 1.43/ 1.23 [1.33] 0.36 −2.14 –5.77 –2.64 
14 * 0.99/ 0.91 [0.95] 1.18/ 1.07 [1.12] 0.17 −2.15 –5.75 –2.65 
15 * 0.87/ 0.75 [0.81] 1.24/ 1.12 [1.18] 0.37 −2.19 –5.61 –2.61 
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complexes 11 and 15 as representative examples, both 
oxidation processes were shown to be chemically reversible 
over 10 cycles (Figures S114 and S115). 
 Complex 7, which features 4 fluorine atoms on the bridging 
unit, displays the lowest first oxidation potential (Eox(1)). As 
expected, increasing to 8 (complex 8) and 10 fluorine atoms 
(complex 9) leads to successively higher oxidation potentials. 
Due to the addition of electron-rich methoxy groups to the 
octafluoro bridging unit, the oxidation potential of complex 10 
is slightly decreased by 0.02 V compared to complex 9. A 
relatively small variation in oxidation potentials (0.04 V) across 
the series 7–10 supports DFT predictions that the bridges in 8 
and 9 behave as ancillary ligands.  
Complexes 7–10, which vary only in the extent of bridge 
fluorination, all feature very similar peak splittings (ΔE1/2 ca. 
0.25 V), indicating similar electronic coupling between the Ir 
centres for this series. 
 Functionalising the ppy ligands of complex 11 with mesityl 
groups does not significantly influence Eox(1) (an increase of 
only 0.02 V is observed compared to complex 9), indicating 
that they have minimal electronic effect.47,48 However, it is 
interesting that the second oxidation potential (Eox(2)) of 11 is 
shifted to a significantly higher potential compared to complex 
9 (0.90 V vs. 0.81 V) leading to a larger ΔE1/2 value of 0.32 V 
for 11 compared to 0.25 V for 9. A tentative explanation is that 
the mesityl groups, could sterically interact over the bridging 
unit (Figure S101). This would lower the molecular flexibility 
and could hinder structural rearrangement to the dication, 
thereby increasing Eox(2) of 11 compared to the more flexible 
complex 9. 
The oxidation potential of 12 is higher than that of 11 by 
0.04 V, suggesting that the bis(trifluoromethyl)-functionalised 
bridge (18) is more strongly electron withdrawing than the 
bis(pentafluorophenyl) bridge (17c).46 The ΔE1/2 value obtained 
for 12 (0.16 V) is also half of that observed for 11, implying 
weak communication between the two iridium centres. This is 
in line with the ancillary nature of the bridge and in agreement 
with DFT (Table S2). The addition of fluorinated 
cyclometalating ligands to complexes meso 13 and rac 13 
further shifts their oxidation potentials to more positive values, 
as expected from DFT, which predicts high HOMO 
contributions from the cyclometalating phenyl rings of complex 
11 (Table S2). The ΔE1/2 values for meso 13 and rac 13 are also 
greater than for complex 11 (by 0.03/ 0.04 V) which may be 
due to the reduced ancillary character of the 
bis(pentafluorophenyl) bridge in these complexes, also in line 
with DFT predictions.  
      Complex 14 has an oxidation potential almost identical to 
meso 13 and rac 13, indicating very similar HOMO energies. 
Analogous to the relationship between complexes 11 and 12, 
complex 14 displays a much lower ΔE1/2 value than either 
diastereomer of complex 13, which suggests a higher ancillary 
character of the bis(trifluoromethyl) bridge (and so weaker Ir---
Ir communication), as inferred by DFT.  
      The first oxidation potential of 15 is cathodically shifted 
compared to complexes 13 (by ca. 0.1 V). This is due to the 
absence of the xylyl spacer which electronically decouples the 
electron donating methylenecyclohexylether group from the 
ppy ligands. Complex 15 also has the largest ΔE1/2 value (0.37 
V), in agreement with DFT which predicts the bridging unit to 
be the least ancillary of the series (Table S2). 
The reduction potentials for 7–15 were also estimated by 
CV. The data for the reduction scans are included in Table 1 
and the voltammograms are shown in Figure S116–125. All 
complexes display irreversible reductions. This adds significant 
error to their accurate determination, complicating the detailed 
analysis of any trends. A similar situation has been previously 
encountered in the study of monoiridium complexes by 
Baranoff and Nazeeruddin et al.54 Nevertheless, the reduction 
onsets for the complexes 7–15 are in the range of −2.1 – –2.4 V 
vs. FcH/ FcH+, which is a reasonable fit with their emission 
energies (discussed below) and are similar to those reported for 
ppy-based monoiridium complexes.55 Generally, 
functionalisation of the cyclometallating ligands of 13−15 with 
electron-withdrawing fluorine atoms decreases their reduction 
potentials compared to those of complexes 7−12 as expected.55 
The reduction potential for 15 is marginally greater than for 13 
and 14 (−2.19 V vs. −2.14/ −2.16 V and −2.15 V), which is 
expected from the DFT data upon direct functionalisation of the 
LUMO-bearing pyridyl moieties with electron-donating 
methylenecyclohexyl ether groups. 
 
 Photophysical data 
The emission spectra for the complexes are shown in Figures 
6–9 and Figures S155–S157 and the key photophysical data are 
given in Table 2. Absorption data are presented in Figure S154 
and Table S3. Complex 7 is nonemissive in DCM solution at 
room temperature, while being highly emissive (PLQY = 61 ± 
10%) when doped into a rigid poly(methyl methacrylate) 
(PMMA) matrix. This is consistent with the data for complex 
1
22, for which the flexible central bridging unit (that DFT 
predicts to have significant HOMO character) can provide a 
pathway for non-radiative quenching of the excited state in 
solution, which can be inhibited by doping the complex into a 
rigid host matrix.   
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Figure 6. Normalised emission spectra of complexes 8–12 in degassed DCM 
solutions at room temperature (λexc 355 nm).  
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 Complexes 8–10 have significantly different photophysical 
properties than 7, in that they are highly emissive in solution 
and in PMMA, with very similar PLQY values in both media. 
This is consistent with rigidification of 8–10 by intramolecular 
π–π stacking, which restricts rotation of the bridge aryl rings. 
This is observed in the solution 19F NMR spectra of 8–10 
(Figures 3, S5, S9, S15 and S18) and removes the requirement 
to impede bridge flexibility by using a rigid matrix such as 
PMMA. 
 Another possible explanation is that for complexes with an 
ancillary bridging unit (Table S2) such as 8 and 9, motion of 
the bridge does not provide as efficient a non-radiative pathway 
to the ground state in solution. However, as complex 10 
features a non-ancillary bridge with notable HOMO character 
(Table S2) while still exhibiting a high solution PLQY (78 ± 
5%), it is evident that intramolecular π–π stacking is the main 
reason for high solution PLQYs in highly fluorinated 
diarylhydrazide-bridged diiridium complexes.  
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Figure 7. Normalised emission spectra of complexes 7–12 doped into PMMA 
at 1 wt. % at room temperature (λexc 355 nm). Inset: photograph of emission 
from a doped PMMA film (left) and degassed DCM solution (right) of rac 11 
under irradiation from a 365 nm UV lamp.   
 The emission spectra of 8–10 are blue shifted compared to 7 
(by ca. 10 nm in PMMA) (Figure 7). This is a result of HOMO 
stabilisation through further fluorination of the bridging units 
(in agreement with electrochemical data – Table 1). Complexes 
8–10 exhibit near identical Commission Internationale de 
L’Éclairage (CIExy) colour coordinates in PMMA of (0.25, 
0.62/0.63) in the green region of the spectrum. The triplet 
energies (ET) for 8–10 (obtained from emission spectra 
recorded in 2-MeTHF at 77 K, Figure S156) are also nearly 
identical (2.56–2.57 eV). These data provide additional 
experimental support for the DFT prediction that the bridges in 
8 and 9 behave as ancillary ligands.  
 The mesityl groups in rac 11 result in a significant increase 
in the radiative rate constant (kr) compared to complex 9 in 
DCM solution (5.30 vs. 3.40 × 105 s-1) and in PMMA (5.18 vs. 
4.41 × 105 s-1). This leads to a small increase in solution PLQY 
(88 ± 5% for rac 11 vs. 76 ± 5% for complex 9), whereas the 
PLQYs in PMMA for 9 and rac 11 are very similar (71 ± 10% 
and 72 ± 10%, respectively). The incorporation of mesityl 
groups is known to increase PLQYs and kr values in 
monoiridium systems.47,48 As mesityl groups have a negligible 
electronic effect, the CIExy coordinates (in both DCM an 
PMMA) and ET values for 9 and rac 11 are nearly identical.
47,48 
 Complex meso 12 is moderately emissive in DCM solution 
(PLQY = 22 ± 5%) and is highly emissive in PMMA (PLQY = 
66 ± 10%). This is due to an order of magnitude decrease in knr 
upon doping the complex into PMMA (Table 2), which can be 
attributed to higher molecular flexibility inferred from the XRD 
data (discussed above, Figure S102). Although meso 12 is not 
rigidified by intramolecular π–π interactions, it is still emissive 
in solution, albeit to a lesser extent than rac 11. This may be 
related to the ancillary nature of the bridging ligand (predicted 
by DFT), which may reduce the efficiency of non-radiative 
quenching through bridge motion, as mentioned above.  
 Other than their solution PLQY values and the presence/ 
absence of intramolecular π–π interactions, complexes rac 11 
and meso 12 display similar theoretical (Table S2), 
electrochemical (Table 1) and photophysical (Table 2) 
properties. A direct comparison therefore serves as good 
evidence that intramolecular π–π interactions contribute 
significantly to the high solution PLQYs of the diarylhydrazide-
bridged complexes.  
 Incorporation of the fluorinated cyclometalating ligand 21 
into the diastereomers meso 13 and rac 13 shifts their emission 
energies into the sky-blue region (Figures 8 and 9). In DCM 
both meso 13 and rac 13 have PLQYs of 47/ 48 ± 5% with 
CIExy coordinates (0.18, 0.36) marginally lower than the 
archetypal sky-blue emitter FIrpic (Figure 8)38,56 (0.19, 0.37), 
even though their λmax values are red shifted compared to FIrpic 
by 2 nm. This is related to their narrower full width at half 
maximum (FWHM) values because of diminished v0,1 vibronic 
shoulders: FWHM FIrpic = 82 nm, meso 13 = 63 nm, rac 13 = 
69 nm. This is again consistent with higher molecular rigidity, 
due to the intramolecular π–π interactions (observed in the 19F 
NMR spectra of meso 13 and rac 13 – Figure S42 and S51). 
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Figure 8. Normalised emission spectra of complexes 13–15 and FIrpic in 
degassed DCM solutions at room temperature (λexc 355 nm). The emission 
spectrum of 15 is poorly resolved due to a low solution PLQY. Inset: (left) 
chemical structure of FIrpic. (Right) photograph of emission from a doped 
PMMA film and degassed DCM solution of rac 13 under irradiation from a 
365 nm UV lamp.  
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Molecular rigidity also influences the Huang-Rhys factor (SM), 
which is proportional to the degree of structural distortion 
which occurs in the excited state of a molecule relative to the 
ground state.57 SM values were estimated for FIrpic, meso 13 
and rac 13 from the relative heights of the v0,0 and v0,1 peaks in 
their 77 K emission spectra (Figure S157, FIrpic spectrum 
obtained from ref. 56).57,58 The following values were obtained: 
FIrpic = 0.7, meso 13 = 0.4, rac 13 = 0.5 (1 s.f.). These values 
indicate a lower intensity vibronic progression for the rigid 
diiridium complexes compared to FIrpic, which is vital for 
obtaining high colour purity. 
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Figure 9. Normalised emission spectra of complexes 13–15 and FIrpic doped 
into PMMA at 1 wt. % at room temperature (λexc 355 nm). Inset: photograph 
of the emission from doped PMMA films of rac 13 (left) and 15 (right) under 
irradiation from a 365 nm UV lamp. 
Similarly, favourable photophysical properties are also 
observed for meso 13 and rac 13 when doped into PMMA: high 
PLQYs of 60/ 65 ± 10% (FIrpic 74 ± 10%) and comparatively 
narrow FWHM values of 55/ 56 nm (FIrpic 67 nm) (Figure 9). 
 These comparatively narrow emission spectra are 
significant as the complexes are predicted to feature non-
ancillary bridging ligands (see the DFT discussed above), 
which will likely lead to excited states with noteworthy 
interligand charge transfer (ILCT) character. ILCT character 
leads to broader, less structured emission due to more diffusely 
localised excited states.58–60 It is expected that the rigidifying 
effect of the intramolecular π–π interactions counteracts this, 
promoting sharper emission bands. These data indicate that 
diiridium complexes show promise as a platform for developing 
blue phosphors with good colour purity.  
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Table 2. Summary of the key photoluminescence data for complexes 7–15 and FIrpic 
*Single diastereomer of unknown absolute configuration. sh = Shoulder.  aSolution photoluminescence measurements were recorded in degassed DCM solutions at ca. 20 °C with an excitation wavelength of 355 nm with quinine 
sulfate in 0.5 M H2SO4 as standard (Φ = 0.546).
61 bMeasured at 77 K using an excitation wavelength of 355 nm. cMeasured in an integrating sphere under air using an excitation wavelength of 355 nm. dWavelength at 10% intensity 
on the blue edge of the spectrum obtained at 77 K. eEstimated using ET = hc/ λ10% em.   
fNon-emissive is defined as PLQY <0.05%. gError = ± 4%. hError = ± 2%. iAll FIrpic data were obtained in-house for direct comparison unless 
otherwise stated. jValues taken from ref 62. τp = 1/ knr + kr.
 DCM solution
a 
2-MeTHF glass
b 
Doped into PMMA 1% wt.
c 
Complex Isomer 
λmax em /nm 
[CIExy] 
PLQY /% 
(± 5%) 
τp /µs 
kr /× 
10
5 
s
–1 
knr /× 10
5 
s
–1 
λmax em /nm 
(λ10% em  /nm)
 d
[ET /eV]
e 
τp 
/μs 
λmax em /nm [CIExy] 
PLQY /% 
(± 10%) 
τp 
/μs 
kr /× 
10
5 
s
–1 
knr /× 
10
5 
s
–1 
7 mixture Non-emissive
f
 500 (490) [2.53] 3.62 516 [0.28, 0.64] 61 1.81 3.37 2.15 
8 mixture 503 [0.27, 0.61] 66 1.84 3.61 1.83 492 (484) [2.56] 3.41 503 [0.25, 0.62] 59 2.00 2.95 2.05 
9 mixture 499 [0.30, 0.58] 76 2.24 3.40 1.07  492 (482) [2.57] 3.55  503 [0.25, 0.62] 71 2.08 3.41 1.39 
10 mixture 505 [0.31, 0.58] 78 2.09 3.73 1.05 493 (485) [2.56] 3.33  507 [0.25, 0.63] 66 2.02 3.27 1.68 
11 rac 502 [0.30, 0.58] 88 1.66 5.30 0.72 494 (485) [2.56] 2.67 507 [0.25, 0.63] 72 1.39 5.18 2.01 
12 meso 500 [0.26, 0.60] 22 0.34 6.41 22.7 491 (483) [2.57] 2.30 504 [0.25, 0.63] 66 1.14 5.79 2.98 
13 
meso 470 [0.18, 0.36] 48 0.69 6.93 7.48 461 (455) [2.72] 2.24 470 [0.16, 0.33] 65 1.19 5.46 2.94 
rac 470 [0.18, 0.36] 47 0.73 6.49 7.23 463 (456) [2.72] 1.78 472 [0.15, 0.33] 60 1.18 5.51 3.39 
14 * 470 [0.16, 0.33] 4
g 
0.07 5.77 135 462 (454) [2.73] 1.92 471 [0.15, 0.33] 46 1.12 4.11 4.82 
15 * 459 [0.20, 0.28] 2
h 
0.11 1.64 89.3 451 (441) [2.81] 2.24 460 [0.15, 0.24] 69 1.62 4.26 1.91 
FIrpic
i - 468 [0.19, 0.37] 73 1.85 3.95 1.46 463 [2.62]j 2.24j 470sh, 493 [0.15, 0.33] 74 1.69 4.38 1.54 
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 Meso 13 and rac 13 feature higher kr values than FIrpic (by 
~20–40%) under directly comparable conditions in both DCM 
solution and PMMA. This may be related to the strong Ir---Ir 
coupling observed in the electrochemistry (Table 1), and results 
in notably shorter τp values in PMMA of 1.18/ 1.19 µs (vs. 1.69 
µs for FIrpic).  
 Enhanced radiative rate constants compared to monoiridium 
analogues have been reported for green to red diiridium 
complexes, which may be due to augmented spin-orbit 
coupling.23,24,26,50,63 Blue phosphors tend to possess excited 
states with more LC character than green emitting 
complexes,64–66 which is an indication of poorer LC/ MLCT 
state mixing (lower MLCT character) and can lead to inherently 
lower kr values and so longer τp. The observations presented 
here indicate that diiridium complexes are promising systems 
for developing blue phosphors with higher kr values and 
therefore shorter τp which is a highly sought-after property.
67 
 In a similar manner to the relationship between rac 11 and 
meso 12, complex 14 is an analogue of 13 which cannot exhibit 
intramolecular π–π interactions between the cyclometalating 
and bridging ligands. As a result, 14 displays a low solution 
PLQY of 4 ± 4%. In PMMA the PLQY of 14 increases to 46 ± 
10%, which is ascribed to a restriction of intramolecular 
motion, evident from the substantial decrease in knr (Table 2). 
The PLQY of 14 in PMMA is, however, significantly lower 
than those for either diastereomer of 13 (60/ 65 ± 10%). This is 
due to: 1) a substantially higher knr value, which crucially 
indicates that intramolecular π–π interactions are also beneficial 
for obtaining high solid state PLQY values in diiridium 
complexes, and 2) a lower kr value (Table 2), which may be 
related to the smaller Ir---Ir coupling in 14 observed in the 
electrochemistry (Table 1).  
 Despite the lack of rigidifying intramolecular π–π 
interactions, 14 exhibits sharp emission similar to 13 (FWHM 
in PMMA = 57 nm) (Figure 9). This is consistent with the 
ancillary nature of the bis(trifluoromethyl) bridge 18, which is 
expected to limit the ILCT character of the excited state. The 
estimated SM value for 14 is 0.6 (1 s.f.): larger than for either 
diastereomer of 13, but still smaller than for FIrpic. These data 
indicate that designing diiridium complexes with highly 
ancillary bridges could be a way to obtain sharp emission from 
such systems. 
  The emission from complex 15 is shifted deeper into the 
blue than for 13 or 14. This is attributed to the LUMO-
destabilising methylenecyclohexylether groups. As well as 
being tentatively observed in the reduction potentials above 
(Table 1), this can also be concluded from the more reliable 
oxidation potential data which indicate that the HOMO of 15 is 
shallower than for 13 or 14. When doped into PMMA, 15 
displays a high PLQY of 69 ± 10%. This is comparable to the 
value obtained for FIrpic under the same experimental 
conditions, while the colour is notably superior: 15 emits at a 
λmax of 460 nm, pushing the CIExy coordinates to a total value 
below 0.4 (0.15, 0.24). Complex 15 also displays a τp of 1.62 µs 
in PMMA, which is short in a doped film for an Ir complex 
with total CIExy  < 0.4/ λmax ≤ 460 nm and a high PLQY.
47,68–71 
This can be attributed to the high kr, which is likely related to 
the dinuclear nature of the complex as mentioned above. 
 Despite the presence of rigidifying intramolecular π–π 
interactions (observed in the 19F NMR spectrum – Figure S68), 
the PLQY for 15 in DCM solution is low (2 ± 2%). This fits a 
trend of decreasing solution PLQY with increasing emission 
energy in the complexes rac 11 (λmax = 502 nm, PLQY = 88 ± 
5%), 13 (λmax = 470 nm, PLQY = 47/ 48 ± 5%) and 15 (λmax = 
459 nm, PLQY = 2 ± 2%) due to incremental order of 
magnitude increases in their knr values (0.72, 7.23/ 7.48 and 
89.3 × 105 s−1). In contrast, all three complexes exhibit high 
PLQYs (> 60%) and similar knr values (1.91–3.39 × 10
5 s−1) 
when doped into PMMA. Therefore, it appears that as the 
excited state energy increases, the rigidifying effect of the 
intramolecular π–π interactions is overcome and their capability 
to promote emission in solution is reduced. 
 Emission in the sky-blue region from diiridium complexes 
with conjugated bridging ligands is unprecedented. It has been 
accomplished by the synergistic choice of bridging and 
cyclometalating ligands. The key role of the bridge is clear as 
there are reports of diiridium complexes bearing dfppy-type 
peripheral ligands for which sky-blue emission was not 
achieved.8,16,72–74 Although diiridium systems have shown 
promise as high performing phosphors in the lower energy 
range (from red through to green),21–24,26,27,50,75 to the best of 
our knowledge no complex displaying λmax (PL) below ca. 490 
nm at room temperature has been reported thus far.22 Mazzanti 
and co-workers reported a fluorinated diiridium complex with a 
vibronic sideband at 477 nm, but the λmax is ca. 510 nm and the 
emission extends to 800 nm.16 The results presented here 
considerably extend the diiridium complex literature, and 
indicate that if the complexes are correctly designed, their 
colour versatility is potentially comparable to monoiridium 
systems.  
Conclusions  
We have developed new concepts in the chemistry of diiridium 
complexes with the synthesis, structural and optoelectronic 
characterisation of a series of highly fluorinated hydrazide-
bridged complexes.  
 Complexes 7–12 represent an ideal platform for 
investigating intramolecular π–π interactions between aryl and 
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perfluoroaryl rings in organometallic systems, both in the solid 
state (by XRD) and in solution (by 19F NMR spectroscopy).  
These interactions are shown to be an innovative way to 
rigidify diiridium complexes, leading to significant and 
advantageous effects on their photophysical properties. 
Electrochemical and computational studies have further 
extended the understanding of these systems. This knowledge 
has been applied to the rational design and synthesis of the first 
reported sky-blue emitting diiridium complexes 13–15. Their 
favourable photophysical properties are a consequence of both 
the dinuclear nature of the complexes and the beneficial 
intramolecular π–π interactions. They possess high PLQYs, 
λmax as low as 460 nm (CIEx+y < 0.4), high kr, relatively short τp, 
and in some cases, notably sharp emission.  The results 
presented here greatly extend the versatility of luminescent 
diiridium complexes by shifting phosphorescence into the sky-
blue region of the visible spectrum with the aid of tailored non-
covalent interactions. It is now a challenge to design and 
implement further structural modifications that could shift the 
emission of diiridium complexes deeper in the blue region. 
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Experimental Section  
General  
1H, 13C and 19F NMR spectra were recorded on Bruker Avance 400 MHz, Varian Mercury 200, and 400 MHz, Varian 
Inova 500 MHz or Varian VNMRS 600 and 700 MHz spectrometers.  All spectra were either referenced against  the 
residual solvent signal or tetramethylsilane (TMS) and peak shifts are reported in ppm. Where assigned, cyclohexyl 
protons are labelled ‘e’ or ‘a’ to denote equatorial or axial positions, respectively. The labels ‘ap. t’ and ‘bs’ denote 
an apparent triplet and a broad singlet, respectively. For 13C NMR assignment the labels * and # denote 2 and 3 
overlapping signals, respectively. Electrospray ionisation (ESI) mass spectra were recorded on a Waters Ltd. TQD 
spectrometer. Atmospheric solids analysis probe (ASAP) mass spectra were recorded on a LCT premier XE 
spectrometer. Matrix-assisted laser desorption time-of-flight (MALDI–TOF) mass spectra were recorded on a Bruker 
Daltonik Autoflex II spectrometer running in positive ion reflectron mode. MALDI–TOF samples were prepared in 
CH2Cl2 (DCM) with trans-2-[3-(4-tert-butylphenyl)-2-methyl-2-propenylidene]malononitrile (DCTB) as the matrix. 
Elemental analyses were obtained on an Exeter Analytical Inc. CE-440 elemental analyser. Thermal analysis was run 
under a helium atmosphere at a rate of 10 °C min−1 using a Perkin-Elmer Pyris 1 instrument. Reactions requiring an 
inert atmosphere were carried out under argon which was first passed through a phosphorus pentoxide column. Thin 
layer chromatography (TLC) was carried out on silica gel (Merck, silica gel 60, F254) or alumina (Merck, neutral 
alumina 60 type E, F254) plates and visualized using UV light (254, 315, 365 nm). Flash chromatography was carried 
out using either glass columns or a Biotage® Isolera OneTM automated flash chromatography machine on 60 micron 
silica gel purchased from Fluorochem Ltd.  
Chemicals 
All commercial chemicals were of ≥95% purity and were used as received without further purification. [Ir(ppy)2µ–
Cl]21 and 4-(2,4,6-trimethylphenyl)-2-chloropyridine2 were synthesised according to literature procedures. All 
solvents used were of analytical reagent grade or higher. Anhydrous solvents were dried through a HPLC column on 
an Innovative Technology Inc. solvent purification system or purchased from Acros (dry diglyme). 
Calculations 
All calculations were carried out with the Gaussian 09 package.3 All optimized S0 geometries of the diiridium 
complexes were carried out using B3LYP4,5 with the pseudopotential (LANL2DZ)6–8 for iridium and 3–21G* basis 
set for all other atoms.9,10All S0 geometries were true minima based on no imaginary frequencies found. Electronic 
structure calculations were also carried out on the optimised geometries at B3LYP/LANL2DZ:3–21G*. The MO 
diagrams and orbital contributions were generated with the aid of Gabedit11 and GaussSum12 packages, respectively. 
X-ray Crystallography 
X-ray diffraction experiments were carried out at 120 K on a Bruker 3-circle diffractometer D8 Venture with a PHOTON 100 
CMOS area detector, using Mo-Kα radiation from a IμS microsource with focussing mirrors and a Cryostream (Oxford 
Cryosystems) open-flow N2 gas cryostat. The absorption correction was carried out by numerical integration based on crystal 
face indexing, using SADABS program.13 The structures were solved by Patterson (7, 11, 12) or direct methods using SHELXS 
2013/1 software14 and refined in anisotropic approximation by full matrix least squares against F2 off all data, using OLEX215  
and SHELXL 2016/6 software.16  
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Electrochemistry 
Cyclic voltammetry experiments were recorded using either BAS CV50W electrochemical analyzer or a a PalmSens 
EmStat2 potentiostat with PSTrace software. A three-electrode system consisting of a Pt disk (Ø = 1.8 mm) as the 
working electrode, a Pt wire as an auxiliary electrode and an Pt wire as a quasireference electrode was used. Cyclic 
voltammetry experiments were conducted at a scan rate of 100 mV/s. Experiments were conducted in dry, degassed 
DCM with n-Bu4NPF6 (0.1 M) as the supporting electrolyte and were referenced internally to ferrocene. Oxidation 
processes are assigned as being electrochemically reversible based on the equal magnitudes of corresponding 
oxidation and reduction peaks. 
Photophysics 
General The absorption spectra were measured on either a Unicam UV2-100 spectrometer operated with the Unicam Vision 
software or a Thermo Scientific Evolution 220 spectrometer with the Thermo Scientific Insight software in quartz cuvettes 
with a path length of 20 mm. The pure solvent was used for the baseline correction. The extinction coefficients were calculated 
using the Beer-Lambert Law, A = εcl. The photoluminescence spectra were recorded on a Horiba Jobin Yvon SPEX Fluorolog 
3-22 spectrofluorometer in quartz cuvettes with a path length of 10 mm. All Ir complexes were measured in degassed DCM 
(repeated freeze-pump-thaw cycles using a turbomolecular pump). The quantum yields of all samples were determined by the 
comparative method relative to. quinine sulphate in 0.5 M H2SO4 (Φ = 0.54617) following the literature procedure.18 The 
quantum yields of complexes doped into poly(methyl methacrylate) (PMMA) thin films were recorded on a Horiba Jobin 
Yvon SPEX Fluorolog 3 using a calibrated Quanta-Φ integrating sphere and were calculated according to the literature 
method.19 Solid state PLQY data were obtained in triplicate from three samples that were prepared in parallel: the calculated 
standard error values were ≤10%. Lifetime measurements were recorded using an N2 laser (337 nm, 10 μJ, 10 Hz) as an 
excitation source in a custom spectrometer which produced a 1 kHz train of pulses of 20 ns duration. The luminescence was 
collected at 90° and focused onto the entrance slit of a monochromator (Bethan TM 300V). The emission was detected by a 
photon counting PMT and the arrival times of photons at the detector determined using a multichannel scaler.  The data were 
transferred to a PC and analysed using non-linear regression. The decay data were fitted to exponential functions. Low 
temperature emission spectra and lifetime data were measured in a DN1704 optical cryostat (Oxford Instruments) with a 
ITC601 temperature controller (Oxford Instruments). 
PMMA film preparation An adaptation of our previously reported method was used.20 This adaptation was possible due to 
the improved solubility of the complexes studied here in chlorobenzene (CB) and is experimentally simpler. 100 µL of a 1 
mg mL–1 solution of the diiridium complex in DCM was added to 1 mL of a 10 mg mL–1 solution of PMMA in CB and the 
resulting solution was stirred open to air at room temperature (ca. 2 h). The solution was then drop-cast using a Gilson 
precision pipette onto a 10 × 1 mm circular quartz disk (UQG Optics Ltd., UK) in a single. 150 µL portion. The substrate 
was heated to ca. 40 ºC overnight on a hot plate under air. Photophysical analysis was then immediately carried out. The 
PLQY values obtained using films prepared in this manner were the same (within experimental error) as those obtained 
using our previously reported method. 
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Synthesis 
The synthesis of 21 (Scheme S1) started with etherification of the xylenol 23 with bromomethylcyclohexane to obtain 
the aryl ether 24 in 98% yield. Subsequent trapping of the lithiated derivative of 24 with SnBu3Cl afforded the 
stannane 25. This was coupled with 4-iodo-2-chloropyridine in a Stille reaction to chemoselectively obtain the 2-
chloropyridine derivative 26. Finally, Suzuki-Miyaura coupling of 26 with 2,4-difluorophenylboronic acid afforded 
21 in 90% yield. 22 was synthesised from 27 via a sequential etherification and cross coupling strategy analogous to 
ligand 21 
 
Scheme S1. Structures and synthetic schemes for the bridging and cyclometalating ligands studied in this work. 
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Complex 7. N,Nʹ-Bis(3,5-difluorobenzoyl)hydrazide (17a) (87 mg, 0.28 mmol, 1.00 eq.), [Ir(ppy)2μ-Cl]2 (300 mg, 
0.28 mmol, 1.00 eq.) and  K2CO3 (116 mg, 0.84 mmol, 3.00 eq.) were added to 2-ethoxyethanol (15 mL) under and 
argon atmosphere and heated to reflux overnight. The reaction mixture was then cooled to room temperature and the 
solvent was removed under reduced pressure. The residue was then dissolved in DCM and suspended onto celite (c.a. 
2 g) under reduced pressure, before being subjected to flash chromatography on silica gel (eluent: gradient n-hexane/ 
DCM sat. K2CO3 3:7 – 0:1). The yellow band was collected and after removing the solvent under reduced pressure, 
the residue was dissolved in a minimal amount of DCM (ca. 20 mL). Addition of methanol (ca. 20 mL) followed by 
reducing the volume of the mixture to 20 mL afforded complex 7 (275 mg, 0.21 mmol, 75%) as a yellow precipitate 
which was isolated via filtration and washed sequentially with methanol followed by pentane. The isolated product 
was a mixture of diastereomers in a ca. 9:1 ratio. MS (MALDI–TOF): m/z 1312.2 [M+]. Calcd. for C58H38F4Ir2N6O2+: 
1312.2; Anal. Calcd. for C58H38F4Ir2N6O2: C, 53.12; H, 2.92; N, 6.41, Calcd. for C58H38F4Ir2N6O2∙0.2CH2Cl2: C, 
52.62; H, 2.91; N, 6.33.  Found:  C, 52.62; H, 2.95; N, 6.27.; 
 
Major diastereomer: 1H NMR (600 MHz, CD2Cl2, TMS) δ (ppm) = 9.00 (ddd, J = 5.7, 1.6, 0.8 Hz, 2HA), 8.70 (dt, J 
= 5.6, 1.2 Hz, 2HB), 8.02 – 7.89 (m, 4H2A), 7.85 – 7.76 (m, 4H2B), 7.54 – 7.45 (m, 4HA,D), 7.36 (dd, J = 7.8, 1.4 Hz, 
2HC), 7.10 (ddd, J = 6.7, 5.7, 2.2 Hz, 2HB), 6.80 (td, J = 7.5, 1.3 Hz, 2HD), 6.68 – 6.58 (m, 4HC,D), 6.41 (td, J = 7.5, 
1.4 Hz, 2HC), 6.17 (tt, J = 9.1, 2.4 Hz, 2HE2), 6.07 – 6.00 (m, 2HD), 5.91 (dd, J = 7.8, 1.2 Hz, 2HC), 5.88 (s, 4HE4); 
19F {1H} NMR (376 MHz, CD2Cl2) δ (ppm) = -110.65 (s, 2F).  
Due to poor solubility in organic solvents, a solution sufficiently concentrated to obtain a 13C NMR spectrum of the 
diastereomeric mixture could not be obtained. The 1H NMR spectrum of the minor diastereomer could not be 
completely deconvoluted due to its low concentration and the presence of overlapping signals. The 1H NMR spectrum 
of the mixture is shown as Figure S1. Single crystals of the meso diastereomer suitable for X-ray diffraction were 
grown by vapour diffusion of methanol into a DCM solution of the complex. 
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Complex 8. N,Nʹ-Bis(2,3,5,6-tetrafluorobenzoyl)hydrazide (17b) (108 mg, 0.28 mmol, 1.00 eq.) was added to dry 
diglyme (10 mL)  with K2CO3 (200 mg, 1.45 mmol, 5.18 eq.) and heated to 50 °C under an argon atmosphere for 30 
min to obtain a pale yellow suspension. [Ir(ppy)2μ-Cl]2 (300 mg, 0.28 mmol, 1.00 eq.) was then added and the mixture 
was heated to 120 °C overnight. The reaction mixture was then cooled to room temperature and the solvent was 
removed under reduced pressure. The residue was dissolved in DCM and suspended onto celite (c.a. 2 g) under 
reduced pressure, before being subjected to flash chromatography on silica gel (eluent: DCM sat. K 2CO3). The 
glowing yellow band was collected and after removing the solvent under reduced pressure, the residue was dissolved 
in a minimal amount of DCM (ca. 10 mL). Addition of hexane (ca. 20 mL) followed by reducing the volume of the 
mixture to 25 mL afforded complex 8 (207 mg, 0.15 mmol, 53%) as a yellow precipitate which was isolated via 
filtration and washed with pentane. The product was isolated as a mixture of diastereomers in a ca. 9:1 ratio. MS 
(MALDI–TOF): m/z 1384.2 [M+]. Calcd. for C58H34F8Ir2N6O2+: 1384.2; Anal. Calcd. for C58H34F8Ir2N6O2: C, 50.36; 
H, 2.48; N, 6.08. Found:  C, 50.06; H, 2.47; N, 6.00; 
 
Major diastereomer: 1H NMR (600 MHz, CD2Cl2, TMS) δ (ppm) = 9.18 (d, J = 5.6 Hz, 2HA6), 8.31 (d, J = 5.6 Hz, 2HB6), 7.97 
– 7.94 (m, 2HA4), 7.93 – 7.87 (m, 6HA3, B4, B3), 7.50 (d, J = 7.1 Hz, 2HC9), 7.46 (ddd, J = 7.5, 5.6, 1.5 Hz, 2HA5), 7.37 (d, J = 
7.2 Hz, 2HD9), 7.14 (ddd, J = 7.2, 5.6, 1.6 Hz, 2HB5), 6.79 (td, J = 7.4, 1.2 Hz, 2HC10), 6.63 – 6.59 (m, 4HC11, D10), 6.47 (td, J 
= 7.5, 1.0 Hz, 2HD11), 6.38 – 6.32 (m, 2HE1), 6.12 (d, J = 7.7 Hz, 2HD12), 5.91 (d, J = 7.4 Hz, 2HC12); 19F {1H} NMR (376 
MHz, CD2Cl2) δ (ppm) =-138.37 (dd, J = 24.5, 12.0 Hz, 2F), -140.73 (dd, J = 23.0, 12.4 Hz, 2F), -141.90 (dd, J = 24.5, 12.4 
Hz, 2F), -145.59 (dd, J = 23.0, 12.0 Hz, 2F). 
Minor diastereomer: 19F NMR (376 MHz, CD2Cl2) δ (ppm) =-139.55 (dd, J = 24.2, 11.7 Hz), -139.80 (dd, J = 23.4, 12.4 Hz), 
-143.09 (dd, J = 24.2, 11.7 Hz), -144.38 (dd, J = 23.4, 12.4 Hz). 
Due to poor solubility in organic solvents, a solution sufficiently concentrated to obtain a 13C NMR spectrum of the 
diastereomeric mixture could not be obtained. The 1H NMR spectrum of the minor diastereomer could not be completely 
deconvoluted due to its low concentration and the presence of overlapping signals. The 1H NMR spectrum of the mixture is 
shown as Figure S4. 
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Complex 9. [Ir(ppy)2μ-Cl]2 (160 mg, 0.15 mmol, 1.00 eq.) and N,Nʹ-bis(pentafluorobenzoyl)hydrazide (17c) (63 mg, 
0.15 mmol, 1.00 eq.) were added to dry diglyme (20 mL) and heated to 120 °C under an argon atmosphere for 24 h. 
The reaction mixture was then cooled to room temperature and the solvent was removed under reduced pressure. The 
residue was then dissolved in DCM and suspended onto celite (c.a. 2 g) under reduced pressure, before being 
subjected to flash chromatography on silica gel (eluent: n-hexane/ DCM sat. K2CO3 1:1 v/v). The glowing yellow 
band was collected and after removing the solvent under reduced pressure, the residue was dissolved in a minimal 
amount of DCM (ca. 10 mL). Addition of hexane (ca. 20 mL) followed by reducing the volume of the mixture to 25 
mL afforded complex 9 (70 mg, 0.05 mmol, 33%) as a yellow precipitate which was isolated via filtration and washed 
with pentane. The product was isolated as a mixture of diastereomers in a ca. 5:4 ratio (meso:rac). MS (MALDI–
TOF): m/z 1420.1 [M+]. Calcd. for C58H32F10Ir2N6O2+: 1420.2; Anal. Calcd. for C58H32F10Ir2N6O2: C, 49.08; H, 2.27; 
N, 5.92. Found:  C, 49.16; H, 2.31; N, 5.89.  
 
1H and 19F NMR 
Meso diastereomer: 1H NMR (700 MHz, CD2Cl2, TMS) δ (ppm) = 8.94 (d, J = 5.4 Hz, 2HB6), 8.69 (d, J = 5.6 Hz, 
2HA6), 7.98 – 7.88 (m, 4HB4,B3), 7.81 – 7.75 (m, 4HA4,A3), 7.51 – 7.48 (m, 2HB5), 7.47 – 7.44 (m, 2HA9), 7.42 – 7.38 
(m, 2HB9), 7.02 (ddd, J = 7.3, 5.6, 2.0 Hz, 2HA5), 6.81 – 6.77 (m, 2HA10), 6.71 – 6.67 (m, 2HB10), 6.64 – 6.59 (m, 
2HA11), 6.54 – 6.48 (m, 2HB11), 6.07 (d, J = 7.7 Hz, 2HB12), 5.96 (dd, J = 7.9, 1.2 Hz, 2HA12); 19F {1H} NMR (376 
MHz, CD2Cl2) δ (ppm) = -142.9 (dd, J = 24.2, 7.8 Hz, 2F), -144.0 (dd, J = 24.4, 7.8 Hz, 2F), -155.8 – -155.9 (m, 2F), 
-161.7 (td, J = 22.8, 7.8 Hz, 2F), -162.1 (td, J = 22.7, 7.7 Hz, 2F). 
Rac diastereomer: 1H NMR (700 MHz, CD2Cl2, TMS) δ (ppm) = 9.13 (d, J = 5.6 Hz, 2HB6), 8.27 (d, J = 5.4 Hz, 
2HA6), 7.98 – 7.88 (m, 8HB4,B3,A4,A3), 7.51 – 7.48 (m, 2HA9), 7.47 – 7.44 (m, 2HB5), 7.42 – 7.38 (m, 2HB9), 7.14 (ddd, 
J = 7.2, 5.6, 1.5 Hz, 2HA5), 6.81 – 6.77 (m, 2HA10), 6.71 – 6.67 (m, 2HB10), 6.64 – 6.59 (m, 2HA11), 6.54 – 6.48 (m, 
2HB11), 6.12 (d, J = 7.8 Hz, 2HB12), 5.90 (dd, J = 7.6, 1.1 Hz, 2HA12); 19F {1H} NMR (376 MHz, CD2Cl2) δ (ppm) = 
-141.6 (d, J = 22.6 Hz, 2F), -145.2 (d, J = 23.7 Hz, 2F), -155.8 – -155.9 (m, 2F), -160.5 – -160.7 (m, 2F), -162.9 – -
163.1 (m, 2F). 
13C NMR 
Meso diastereomer: 13C NMR (176 MHz, CD2Cl2, TMS) δ (ppm) = 149.2 (CA6), 147.93 (CB6), 131.8 (CB12), 131.5 (CA12), 
129.2 (CA11), 128.9 (CB11), 123.8 (CA9), 123.8 (CB9), 121.6 (CA10), 121.6 (CB5), 121.5 (CA5), 119.6 (CB10). 
Rac diastereomer: 13C NMR (176 MHz, CD2Cl2, TMS) δ (ppm) = 149.8 (CB6), 148.4 (CA6), 131.8 (CA12), 131.5 (CB12), 129.1 
(CA11), 128.8 (CB11), 123.5 (CB9), 121.9 (CA5), 121.7 (CA10), 121.7 (CA9), 121.5 (CB5), 120.0 (CB10). Due to low solubility in 
organic solvents, extensive coupling to 19F nuclei and overlapping signals due to the presence of two diastereomers, some of 
the 13C NMR signals could not be unambiguously assigned. All signals that could be clearly identified in the 13C, 1H–13C 
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HSQC and 1H–13C HMBC NMR spectra are reported. The spectra are included as Figures S8, S11 and S12. To obtain a sample 
of the meso (ɅΔ) isomer, which was used to grow crystals suitable for X-ray diffraction, the diastereomeric mixture was 
suspended in toluene at a concentration of 1 mg/ mL. The suspension was refluxed for 20 minutes and then hot filtered to 
obtain a sample of the meso (ɅΔ) isomer as the filtrand. Crystals were grown by layering a near-saturated DCM solution of 
the complex with hexane. 
 
Complex 10. N,Nʹ-Bis(2,3,5,6-tetrafluoro-4-methoxybenzoyl)hydrazide (17d) (62 mg, 0.14 mmol, 1.00 eq.) was added to 
dry diglyme (5 mL)  with K2CO3 (96 mg, 0.70 mmol, 5.00 eq.) and heated to 50 °C under an argon atmosphere for 
30 min to obtain a pale yellow suspension. [Ir(ppy)2μ-Cl]2 (150 mg, 0.14 mmol, 1.00 eq.) was then added and the 
mixture was heated to 120 °C overnight. The reaction mixture was then cooled to room temperature and the solvent 
was removed under reduced pressure. The residue was then dissolved in DCM and suspended onto celite (c.a. 2 g) 
under reduced pressure, before being subjected to flash chromatography on silica gel (eluent: DCM sat. K2CO3). The 
glowing yellow band was collected and after removing the solvent under reduced pressure, the residue was dissolved 
in a minimal amount of DCM (ca. 5 mL). Addition of methanol (ca. 20 mL) followed by reducing the volume of the 
mixture to ca. 20 mL afforded complex 10 (57 mg, 0.04 mmol, 28%) as a yellow precipitate which was isolated via 
filtration and washed with pentane. The product was obtained as a mixture of diastereomers in a ca. 5:4 ratio. MS 
(MALDI–TOF): m/z 1444.2 [M+]. Calcd. for C60H38F8Ir2N6O4+: 1444.2; Anal. Calcd. for C60H38F8Ir2N6O4: C, 49.93; H, 2.65; 
N, 5.82, Calcd. for C60H38F8Ir2N6O4∙0.2CH2Cl2: C, 49.51; H, 2.65; N, 5.75. Found:  C, 49.50; H, 2.76; N, 5.70. 
 
1H and 19F NMR 
Major diastereomer: 1H NMR (600 MHz, CD2Cl2, TMS) δ (ppm) = 9.16 (d, J = 5.6 Hz, 2HA), 8.27 (dt, J = 5.5, 1.2 Hz, 2HB), 
7.96 – 7.86 (m, 8H2A, 2B), 7.50 – 7.41 (m, 4HA,C), 7.40 – 7.36 (m, 2HD), 7.11 (ddd, J = 7.3, 5.7, 1.7 Hz, 2HB), 6.80 – 6.75 (m, 
2HC), 6.65 – 6.57 (m, 4HC,D), 6.50 – 6.43 (m, 2HD), 6.11 (d, J = 7.7 Hz, 2HD), 5.91 (dd, J = 7.8, 1.2 Hz, 2HC), 3.86 (s, 6HMeO); 
19F {1H} NMR (376 MHz, CD2Cl2) δ (ppm) = -143.2 – -143.5 (m, 2F), -146.6 – -146.8 (m, 2F), -157.7 – -157.9 (m, 2F), -
159.4 – -159.7 (m, 2F).  
Minor diastereomer: 1H NMR (600 MHz, CD2Cl2, TMS) δ (ppm) = 8.95 (dd, J = 5.4, 1.3 Hz, 2HA), 8.72 (d, J = 5.7 Hz, 2HB), 
7.96 – 7.86 (m, H2A), 7.79 – 7.73 (m, 4H2B), 7.50 – 7.41 (m, HA,C), 7.40 – 7.36  (m, 2HD), 7.01 (ddd, J = 7.2, 5.7, 2.0 Hz, 2HB), 
6.80 – 6.75  (m, 2HC), 6.65 – 6.57 (m, 4HC,D), 6.50 – 6.43  (m, 2HD), 6.06 (d, J = 7.7 Hz, 2HD), 5.96 (dd, J = 7.8, 1.1 Hz, 2HC), 
3.86 (s, 6HMeO); 19F {1H} NMR (376 MHz, CD2Cl2) δ (ppm) = -144.4 – -144.7 (m, 2F), -145.5 – -145.8 (m, 2F), -158.5 – -
158.9 (m, 4F).  
13C NMR 
Diasteromeric mixture: 13C NMR (151 MHz, CD2Cl2, TMS) δ (ppm) = 169.3, 168.8, 168.6, 168.5, 165.2, 151.5 –148.5 (CArF), 
145.0, 144.9, 143.6, 143.5, 138.1, 137.8, 137.6, 132.5, 132.3, 132.1, 132.1, 129.6, 129.6, 129.3, 129.2, 124.3, 124.3, 124.0, 
124.0, 122.4, 122.3, 122.1, 122.0, 122.0, 120.2, 120.1, 119.7, 119.3, 119.3, 118.9, 62.0. Due to low solubility in organic 
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solvents, extensive coupling to 19F nuclei and overlapping signals due to the presence of two diastereomers, some of the 13C 
NMR signals could not be unambiguously assigned. All signals that could be clearly identified in the 13C, 1H–13C HSQC and 
1H–13C HMBC NMR spectra are reported. The spectra are included as Figures S17, S20 and S21. Single crystals of the rac 
diastereomer suitable for X-ray diffraction were grown by layering a near-saturated DCM solution of the complex with hexane. 
 
Complex rac 11. N,Nʹ-Bis(pentafluorobenzoyl)hydrazide (17c) (82 mg, 0.19 mmol, 1.00 eq.) was added to dry 
diglyme (15 mL) with K2CO3 (80 mg, 0.70 mmol, 2.98 eq.) and heated to 50 °C under an argon atmosphere for 30 
min to obtain a pale yellow suspension. [Ir(mesppy)2μ-Cl]2 (300 mg, 0.19 mmol, 1.00 eq.) was then added and the 
mixture was heated to 120 °C overnight. The reaction mixture was then cooled to room temperature and the solvent 
was removed under reduced pressure. The residue was then dissolved in DCM and suspended onto celite (c.a. 2 g) 
under reduced pressure, before being subjected to flash chromatography on silica gel (eluent: gradient n-hexane/ 
DCM sat. K2CO3 9:1–1:1 v/v). First to elute was the rac (ɅɅ/ ΔΔ) diastereomer, which after removal of the solvent 
was dissolved in a minimal amount of DCM (ca. 5 mL). Addition of hexane (ca. 20 mL) followed by reducing the 
volume of the mixture to ca. 20 mL afforded complex rac 11 as a yellow precipitate which was isolated via filtration 
and washed with pentane (115 mg, 0.6 mmol, 31%).  
 
1H NMR (700 MHz, CD2Cl2) δ (ppm) = 9.27 (d, J = 5.7 Hz, 2HA6), 8.44 (d, J = 5.6 Hz, 2HB6), 7.71 (s, 2HB3), 7.69 
(s, 2HA3), 7.46 (d, J = 7.7 Hz, 2HB9), 7.35 (d, J = 7.7 Hz, 2HA9), 7.21 (dd, J = 5.8, 1.7 Hz, 2HA5), 7.05 (s, 2HmesAr), 
7.04 (s, 4HmesAr), 7.01 (s, 2HmesAr), 6.94 (dd, J = 5.7, 1.7 Hz, 2HB5), 6.80 (t, J = 7.7 Hz, 2HB10), 6.70 (t, J = 7.3 Hz, 
2HA10), 6.69 – 6.65 (m, 2HB11), 6.62 (t, J = 7.4 Hz, 2HA11), 6.41 (d, J = 7.8 Hz, 2HA12), 5.99 (d, J = 8.4 Hz, 2HB12), 
2.37 (s, 6HmesMe), 2.36 (s, 6HmesMe), 2.29 (s, 6HmesMe), 2.21 (s, 6HmesMe), 2.13 (s, 6HmesMe), 2.09 (s, 6HmesMe); 19F NMR 
{1H} (376 MHz, CD2Cl2) δ (ppm) = -141.9 (dd, J = 25.2, 7.7 Hz, 2F), -145.1 – -145.2 (m, 2F), -155.9 (t, J = 21.6 Hz, 
2F), -160.2 – -160.4 (m, 2F), -162.9 (ddd, J = 23.3, 21.0, 7.9 Hz, 2F); 13C NMR (176 MHz, CD2Cl2) δ (ppm) = 168.1 
(CA2), 167.9 (CB2), 151.9 (CA4), 151.6 (CB4), 150.8 (CA7), 149.8 (CA6), 148.4 (CB6), 147.7 (CB7), 144.7 (CB8), 143.0 
(CA8), 135.0 – 135.8 (Cmes quart carbons), 131.8 (CB12), 131.7 (CA12), 129.1 (CB11), 128.9 (CA11), 128.4 (CmesAr), 128.4# 
(CmesAr), 123.9 (CB9), 123.6 (CA9), 123.1 (CA5), 122.9 (CB5), 121.8 (CB10), 120.5 (CA3), 119.9 (CB3), 119.5 (CA10), 
20.8* (CmesMe), 20.4 (CmesMe), 20.3 (CmesMe), 20.1 (CmesMe), 20.0 (CmesMe), Due to low solubility in organic solvents 
and extensive coupling to 19F nuclei, some of the quaternary 13C NMR signals could not be identified.  All signals 
that could be clearly identified in the 13C, 1H–13C HSQC and 1H–13C HMBC NMR spectra are reported. The spectra 
are included as Figures S23, S28 and S29. MS (MALDI–TOF): m/z 1892.3 [M+]. Calcd. for C94H72F10Ir2N6O2+: 
1892.5; Anal. Calcd. for C94H72F10Ir2N6O2: C, 59.67; H, 3.84; N, 4.44, Calcd. for C94H72F10Ir2N6O2∙0.4CH2Cl2: C, 
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58.87; H, 3.81; N, 4.36.  Found:  C, 58.78; H, 3.73; N, 4.36.  Single crystals suitable for X-ray diffraction were grown 
by vapour diffusion of hexane into a DCM solution of the complex. A second yellow band presumed to contain the 
meso (ɅΔ) diastereomer slowly eluted from the column after the rac (ɅɅ/ ΔΔ) diastereomer, but due to very low 
solubility it could not be isolated in an analytically pure form. 
 
 
Complex meso 12. Bis(trifluoromethyl)hydrazide (18) (43 mg, 0.19 mmol, 1.00 eq.), [Ir(mesppy)2μ-Cl]2 (300 mg, 
0.19 mmol, 1.00 eq.) and K2CO3 (80 mg, 0.70 mmol, 2.98 eq.) were added to 2-ethoxyethanol (15 mL) under and 
argon atmosphere and heated to reflux overnight. The reaction mixture was then cooled to room temperature and the 
solvent was removed under reduced pressure. The residue was then dissolved in DCM and suspended onto celite (c.a. 
2 g) under reduced pressure, before being subjected to flash chromatography on silica gel (eluent: gradient n-hexane/ 
DCM sat. K2CO3 9:1–1:1 v/v). The glowing yellow band was collected and after removing the solvent under reduced 
pressure, the residue was dissolved in a minimal amount of DCM (ca. 5 mL). Addition of hexane (ca. 20 mL) followed 
by reducing the volume of the mixture to ca. 20 mL afforded complex meso 12 as a yellow precipitate which was 
isolated via filtration and washed with pentane (200 mg, 0.12 mmol, 61%). A single diastereomer (ɅΔ) was obtained.  
 
1H NMR (700 MHz, THF-d8) δ (ppm) = 8.74 (d, J = 5.6 Hz, 2HA6), 8.63 (d, J = 5.7 Hz, 2HB6), 7.84 (d, J = 1.8 Hz, 
2HA3), 7.79 (d, J = 1.8 Hz, 2HB3), 7.56 (dd, J = 7.9, 1.3 Hz, 2HA9), 7.53 (dd, J = 7.9, 1.3 Hz, 2HB9), 7.25 (dd, J = 5.7, 
1.9 Hz, 2HA5), 7.01 – 6.99  (m, 4HA15’,B15’), 6.97 (s, 2HB15), 6.90 – 6.87 (m, 4HA15, B5), 6.70 (td, J = 7.6, 7.1, 1.2 Hz, 
2HB10), 6.65 (ddd, J = 7.9, 6.9, 1.2 Hz, 2HA10), 6.57 (ddd, J = 8.2, 7.0, 1.3 Hz, 2HB11), 6.53 (ddd, J = 8.1, 6.9, 1.3 Hz, 
2HA11), 6.30 (d, J = 7.8 Hz, 2HA12), 6.05 (dd, J = 7.9, 1.2 Hz, 2HB12), 2.35 (s, 6HBMe16), 2.32 (s, 6HAMe16), 2.18 (s, 
6HAMe14’), 2.15 (s, 6HBMe14’), 1.91 (s, 6HBMe14), 1.86 (s, 6HAMe14); 19F {1H} NMR (376 MHz, CD2Cl2) δ (ppm) = -
67.0 (s, 6F); 13C NMR (176 MHz, THF-d8) δ (ppm) = 170.8 (CA2), 169.9 (CB2), 152.5 (CB4), 152.3 (CA4), 150.6 (CB6), 
150.3 (CA7), 149.4 (CA6), 146.5 (CB7), 145.2 (CB8), 145.0 (CA8), 138.7 (Cmes quart), 138.5 (Cmes quart), 137.3 – 135.9 
(Cmes quart carbons), 134.6 (CA12), 132.9 (CB12), 130.4 (CB11), 130.0 (CA11), 130.0* (CA15’,B15’), 129.9 (CB15), 129.8 (CA15), 
125.7 (CB9), 125.4 (CA9), 124.5 (CB5), 124.13 (CA5), 122.7 (CB10), 121.8 (CB3), 121.7 (CA3), 121.2 (CA10), 22.0* 
(CA16,B16), 21.6 (CA14), 21.5 (CB14), 21.5 (CA14’), 21.4 (CB14’), Due to low solubility in organic solvents some of the 
quaternary 13C NMR signals could not be identified.  All signals that could be clearly identified in the 13C, 1H–13C 
HSQC and 1H–13C HMBC NMR spectra are reported. The spectra are included as Figures S32, S36 and S37. MS 
(MALDI–TOF): m/z 1696.3 [M+]. Calcd. for C84H72F6Ir2N6O2+: 1696.5; Anal. Calcd. for C84H72F6Ir2N6O2: C, 59.49; 
H, 4.28; N, 4.96, Calcd. for C84H72F6Ir2N6O2∙0.5CH2Cl2: C, 58.38; H, 4.23; N, 4.83. Found:  C, 58.04; H, 4.25; N, 
S11 
 
4.71. Single crystals suitable for X-ray diffraction were grown by vapour diffusion of hexane into a THF solution of 
the complex. 
 
 
Complexes meso 13 and rac 13. [Ir(COD)μ-Cl]2 (200 mg, 0.30 mmol, 1.00 eq.) and 2-(2,4-difluorophenyl)-4-(2,6-
dimethyl-4-(methylcyclohexyloxy)phenyl)pyridine (21)  (534 mg, 1.32 mmol, 4.4 eq.) were added to 2-ethoxyethanol 
(10 mL) and heated to reflux under an argon atmosphere for 4 h. The reaction mixture was then cooled to room 
temperature and the solvent removed under reduced pressure. The residue was then dissolved in DCM (ca. 10 mL) 
and  hexane was added (ca. 30 mL). The solvent volume was reduced to ca. 10 mL under reduced pressure. A yellow 
precipitate formed which was filtered and washed with pentane (ca. 20 mL) to isolate the intermediate μ-dichloro-
bridged diiridium complex (463 mg, 0.22 mmol, 75%) which was used without further purification (1H NMR data 
were consistent with the proposed structure – Figure S39). The obtained dichloro dimer was combined with N,Nʹ-
bis(pentafluorobenzoyl)hydrazide (17c) (94 mg, 0.22 mmol, 1.00 eq.) and K2CO3 (77 mg, 0.56 mmol, 2.50 eq.) and 
suspended in dry diglyme (15 mL) under argon. It was subsequently heated to 120 °C overnight. The reaction mixture 
was then cooled to room temperature and the solvent removed under reduced pressure. To the residue was added 
DCM (10 mL), and the resulting mixture was sonicated for 5 min. Hexane (30 mL) was then added, before the solvent 
volume was reduced to ca. 30 mL. The mixture was filtered to obtain a yellow powder and a yellow/orange filtrate. 
Both the filtrate and filtrand were retained.  
Filtrand 
The filtrand was further purified by flash chromatography on silica gel (eluent: n-hexane/ DCM sat. K2CO3 4:6 v/v). 
After evaporation of the column solvent, the residue was precipitated from DCM/ hexane, filtered and washed with 
pentane to afford the presumed meso (ɅΔ) diastereomer (meso 13) (150 mg, 0.06 mmol, 21% from [Ir(COD)μ-Cl]2).  
Filtrate 
The filtrate was evaporated and the residue was refluxed in methanol (20 mL) for 5 min. The mixture was then cooled 
in a freezer (−18 °C) for 1 h before being filtered to obtain a yellow precipitate, which was further purified by flash 
chromatography on silica gel (eluent: n-hexane/ toluene 6:4 v/v). After evaporation of the column solvent, the residue 
was precipitated from DCM/ hexane, filtered and washed with pentane to afford rac 13 (80 mg, 0.03 mmol, 11% 
from [Ir(COD)μ-Cl]2).  
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meso 13: 1H NMR (600 MHz, CD2Cl2) δ (ppm) = 8.93 (d, J = 5.8 Hz, 2HA6), 8.76 (d, J = 5.8 Hz, 2HB6), 8.10 (s, 2HA3), 8.01 
(s, 2HB3), 7.34 (dd, J = 5.7, 1.8 Hz, 2HA5), 6.88 (dd, J = 5.8, 1.8 Hz, 2HB5), 6.78 – 6.72 (m, 6HE3,E3’,F3’), 6.65 (bs, 2HF3), 6.38 
– 6.32 (m, 2HC4), 6.31 – 6.25 (m, 2HD4), 5.66 (dd, J = 8.5, 2.0 Hz, 2HD6), 5.38 (dd, J = 8.9, 2.4 Hz, 2HC6), 3.85 (d, J = 6.4 Hz, 
4HCH2), 3.81 (d, J = 6.4 Hz, 4HCH2), 2.18 (bs, 6HEMe/EMe’), 2.16 (bs, 6HFMe/FMe’), 1.98 −1.90 (m, 20HCy,EMe/EMe’,FMe/FMe’), 1.82 
(td, J = 7.7, 3.7 Hz, 12HCy), 1.76 (d, J = 11.7 Hz, 4HCy), 1.41 – 1.32 (m, 8HCy), 1.29 – 1.26 (m, 4HCy), 1.18 – 1.09 (m, 8HCy) 
The 1H environments on rings E and F resolve due to restricted rotation. Exchange is observed in 1H−1H NOESY 
and 1H−1H ROESY experiments (Figures S47 and S48); 19F NMR (376 MHz, CD2Cl2) δ (ppm) = -108.0 (d, J = 10.2 Hz, 
2F), -108.3 (d, J = 10.1 Hz, 2F), -109.7 (d, J = 10.2 Hz, 2F), -110.0 (d, J = 10.2 Hz, 2F), -142.0 (d, J = 21.2 Hz, 2F), -143.4 
(d, J = 20.5 Hz, 2F), -154.7 (t, J = 20.8 Hz, 2F), -161.1 (td, J = 22.4, 7.8 Hz, 2F), -161.7 (td, J = 23.9, 21.7, 7.5 Hz, 2F); 13C 
NMR (176 MHz, CD2Cl2) δ (ppm) = 148.6 (CB6), 147.7 (CA6), 125.0 (CA3), 124.9 (CB3), 123.93 (CA5), 123.59 (CB5), 113.8 
(CF3), 113.7# (CF3’,E3,E3’), 113.6 (CD6), 113.5 (CC6), 98.2 (CC4), 96.0 (CD4), 73.5 (CCH2), 73.43 (CCH2), 37.8* (CCy), 29.9* (CCy), 
26.6* (CCy), 25.8* (CCy), 20.7 (CFMe/FMe’), 20.6 (CEMe/EMe’), 20.4 (CFMe/FMe’), 20.3 (CEMe/EMe’), Due to low solubility in organic 
solvents and extensive coupling to 19F nuclei, some quaternary 13C NMR signals could not be identified.  All signals that could 
be clearly identified in the 13C, 1H–13C HSQC and 1H–13C HMBC NMR spectra are reported. The spectra are included as 
Figures S41, S45 and S46. MS (MALDI–TOF): m/z 2428.6 [M+]. Calcd. for C118H104F18Ir2N6O6+: 2428.7; Anal. Calcd. 
for C118H104F18Ir2N6O6: C, 58.36; H, 4.32; N, 3.46, Calcd. for C118H104F18Ir2N6O6∙0.3CH2Cl2: C, 57.90; H, 4.30; N, 3.42.  
Found:  C, 57.83; H, 4.34; N, 3.36.  
 
rac 13: 1H NMR (700 MHz, CD2Cl2, TMS) δ (ppm) = 9.18 (d, J = 5.8 Hz, 2HA6), 8.35 (d, J = 5.7 Hz, 2HB6), 8.08 (s, 
4HA3,B3), 7.28 (d, J = 5.7 Hz, 2HA5), 7.01 – 6.98 (m, 2HB5), 6.76 – 6.71 (m, 8HE3,E3’,F3,F3’), 6.35 (t, J = 10.5 Hz, 2HC4), 
6.29 (t, J = 10.6 Hz, 2HD4), 5.84 (d, J = 8.7 Hz, 2HD6), 5.36 – 5.34 (m, 2HC6), 3.82 – 3.79 (m, 8HCH2), 2.30 (bs, 
6HFMe/FMe’), 2.22 (bs, 6HEMe/EMe’), 2.11 (bs, 6HFMe/FMe’), 2.09 (bs, 6HEMe/EMe’), 1.89 (d, J = 12.8 Hz, 8HCy), 1.79 (d, J 
= 13.8 Hz, 12HCy), 1.73 (d, J = 12.8 Hz, 4HCy), 1.34 (q, J = 13.1 Hz, 8HCy), 1.29 – 1.22 (m, 4HCy), 1.09 (q, J = 12.8 
Hz, 8HCy) The 1H environments on rings E and F partially resolve due to restricted rotation. Exchange is suspected 
from the 1H−1H NOESY experiment (Figure S56); 19F {1H} NMR (376 MHz, CD2Cl2) δ (ppm) = -107.9 (d, J = 10.2 
Hz, 2F), -108.5 (d, J = 10.2 Hz, 2F), -109.7 – -109.8 (m, 2F), -109.8 – -109.9 (m, 2F), -141.0 (d, J = 24.1 Hz, 2F), -
144.5 (d, J = 22.6 Hz, 2F), -154.7 (t, J = 20.8 Hz, 2F), -159.9 – -160.2 (m, 2F), -161.9 (td, J = 22.8, 22.2, 7.7 Hz, 2F); 
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13C NMR (176 MHz, CD2Cl2) δ (ppm) = 164.9 (CA2), 164.4 (CB2), 162.8 (d, J = 256 Hz, CD5), 162.4 (d, J = 251 Hz, 
CC5), 153.2 (CA4), 153.1 (CB4), 159.2* (CE/F), 148.4 (CA6), 148.1 (CB6), 136.6* (CE/F), 130.5* (CE/F), 125.1 (CA3), 
124.7 (CB3), 123.9 (CA5), 123.7 (CB5), 113.9 (CC6), 113.7* (CE/F), 113.7* (CE/F), 113.6 (CD6), 98.3 (CC4), 95.9 (CD4), 
73.5* (CCH2), 37.7* (CCy), 29.9* (CCy), 26.5* (CCy), 25.8*(CCy), 20.8 (CEMe/EMe’), 20.6 (CFMe/FMe’), 20.5 (CFMe/FMe’), 
20.5 (CEMe/EMe’), Due to low solubility in organic solvents and extensive coupling to 19F nuclei, some of the quaternary 13C 
NMR signals could not be identified.  All signals that could be clearly identified in the 13C, 1H–13C HSQC and 1H–13C HMBC 
NMR spectra are reported. The spectra are included as Figures S50, S54 and S55. MS (MALDI–TOF): m/z 2428.6 [M+]. 
Calcd. for C118H104F18Ir2N6O6+: 2428.7; Anal. Calcd. for C118H104F18Ir2N6O6: C, 58.36; H, 4.32; N, 3.46, Calcd. for 
C118H104F18Ir2N6O6∙0.5CH2Cl2: C, 57.60; H, 4.28; N, 3.40.  Found:  C, 57.46; H, 4.32; N, 3.42. Crystals suitable for X-ray 
diffraction fell overnight from a saturated solution of the complex in CD2Cl2. 
 
Complex 14. [Ir(COD)μ-Cl]2 (94 mg, 0.14 mmol, 1.00 eq.) and 2-(2,4-difluorophenyl)-4-(2,6-dimethyl-4-
(methylcyclohexyloxy)phenyl)pyridine (21)  (250 mg, 0.62 mmol, 4.4 eq.) were added to 2-ethoxyethanol (5 mL) and 
heated to reflux under an argon atmosphere for 4 h to generate the μ-dichloro-bridged diiridium complex in-situ. The 
reaction mixture was then cooled to room temperature, before bis(trifluoromethyl)hydrazide (18) (34 mg, 0.14 mmol, 
1.00 eq.), and K2CO3 (58 mg, 0.42 mmol, 3.00 eq.) were added. The reaction mixture was then heated to reflux 
overnight, before being cooled to room temperature and the solvent removed under reduced pressure. The residue 
was dissolved in DCM, suspended onto celite (c.a. 2 g) under reduced pressure and subjected to flash chromatography 
on silica gel (eluent: gradient n-hexane/ DCM sat. K2CO3 8:2–2:8 v/v). The yellow band was collected and the column 
solvent was removed under reduced pressure. The residue was heated to reflux in THF (25 mL) for 20 min and then 
hot filtered to obtain a yellow powder (25 mg, 0.01 mmol, 8%). A second crop was obtained by reducing the filtrate 
to 10 mL and repeating the process (60 mg, 0.03 mmol, 19%). The recovered solids from both filtrations were 
combined to afford complex (14) (85 mg, 0.04 mmol, 27%) as a single diastereomer.  
 
1H NMR (700 MHz, CD2Cl2, TMS) δ (ppm) = 8.57 (d, J = 5.7 Hz, 2HA6), 8.42 (d, J = 5.7 Hz, 2HB6), 8.13 (s, 2HA3), 
8.06 (s, 2HB3), 7.20 (dd, J = 5.7, 1.9 Hz, 2HA5), 6.79 (dd, J = 5.8, 1.9 Hz, 2HB5), 6.73 (bs, 2HE3), 6.72 (bs, 2HF3), 6.70 
(bs, 2HF3’), 6.61 (bs, 2HE3’), 6.42 (ap. t, J = 10.2 Hz, 2HC4), 6.36 (ap. t, J = 10.6 Hz, 2HD4), 5.70 (dd, J = 9.1, 2.1 Hz, 
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2HD6), 5.47 (dd, J = 9.0, 2.4 Hz, 2HC6), 3.82 (d, J = 6.4 Hz, 4HCH2), 3.79 (d, J = 6.1 Hz, 4HCH2), 2.17 (bs, 6HEMe/EMe’), 
2.14 (bs, 6HFMe/FMe’), 1.92 (bs, 6HFMe/FMe’), 1.91 – 1.81 (m, 8HCy), 1.84 (bs, 6HEMe/EMe’), 1.82 – 1.77 (m, 12HCy), 1.74 
(d, J = 13.0 Hz, 4HCy), 1.39 – 1.31 (m, 8HCy), 1.29 – 1.23 (m, 4HCy), 1.13 – 1.09 (m, 8HCy) The 1H environments on 
rings E and F resolve due to restricted rotation. Exchange is suspected from the 1H−1H NOESY experiment (Figure 
S64); 19F {1H} NMR (376 MHz, CD2Cl2) δ (ppm) = -67.0 (s, 6FCF3), -107.6 (d, J = 10.2 Hz, 2FAr), -109.4 (d, J = 9.8 
Hz, 2FAr), -109.6 (d, J = 10.2 Hz, 2FAr), -111.2 – -111.3 (m, 2FAr); 13C NMR (176 MHz, CD2Cl2) δ (ppm) = 165.7 (CA2), 
164.6 (CB2), 159.2 (CE or F), 159.1 (CE or F), 152.9 (CB4), 152.7 (CA4), 148.2 (CB6), 146.9 (CA6), 125.1 (CB3), 124.9 
(CA3), 123.7 (CB5), 123.3 (CA5), 114.7 (CD6), 113.7# (CE3/E3’/F3’), 113.6 (CF3), 113.6 (CC6), 98.4 (CC4), 96.5 (CD4), 73.5 
(CCH2), 73.4 (CCH2), 37.8* (CCy), 29.8* (CCy), 26.6* (CCy), 25.8* (CCy), 20.6 (CEMe/EMe’), 20.6 (CFMe/FMe’), 20.6 
(CFMe/FMe’), 20.5 (CEMe/EMe’), Due to low solubility in organic solvents, some quaternary 13C NMR signals could not be 
identified. All signals that could be clearly identified in the 13C, 1H–13C HSQC and 1H–13C HMBC NMR spectra are reported. 
The spectra are included as Figures S58, S62 and S63. MS (MALDI–TOF): m/z 2232.2 [M+]. Calcd. for 
C108H104F14Ir2N6O6+: 2232.7. 
 
Complex 15. [Ir(COD)μ-Cl]2 (200 mg, 0.30 mmol, 1.00 eq.) and 2-(2,4-difluorophenyl)-4-
(methylcyclohexyloxy)phenyl pyridine (22)  (366 mg, 1.21 mmol, 4.05 eq.) were added to 2-ethoxyethanol (15 mL) 
and heated to reflux under an argon atmosphere for 4 h. The reaction mixture was then cooled to room temperature 
and hexane was added (ca. 30 mL). The mixture was cooled in a fridge (ca. 3 °C) for 1 h. A yellow precipitate formed 
which was filtered and washed with pentane (ca. 20 mL) to isolate the intermediate μ-dichloro-bridged diiridium 
complex (403 mg, 0.24 mmol, 80%) which was used without further purification (1H NMR data were consistent with 
the proposed structure – Figure S65). The obtained dichloro dimer was combined with N,Nʹ-
bis(pentafluorobenzoyl)hydrazide (17c) (102 mg, 0.24 mmol, 1.00 eq.) and K2CO3 (84 mg, 0.60 mmol, 2.50 eq.) and 
suspended in dry diglyme (15 mL) under argon. It was subsequently heated to 120 °C overnight. The reaction mixture 
was then cooled to room temperature and diluted with hexane (ca. 70 mL). A yellow precipitate formed which was 
filtered and washed with pentane (ca. 20 mL). The obtained solid was then dissolved in DCM and suspended onto 
celite (c.a. 2 g) under reduced pressure, before being subjected to flash chromatography on silica gel (eluent: n-
hexane/ DCM sat. K2CO3 1:1 v/v). The faint yellow band was collected and after removing the solvent under reduced 
pressure, the residue was dissolved in minimal DCM (ca. 15 mL). Hexane was added (ca. 20 mL) and the volume 
was reduced to 20 mL After collecting the precipitate by filtration and washing with pentane complex 15 was obtained 
as a yellow solid (130 mg, 0.6 mmol, 22% from [Ir(COD)μ-Cl]2). A single diastereomer was obtained. 
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1H NMR (700 MHz, CD2Cl2, TMS) δ (ppm)= 8.73 (d, J = 6.5 Hz, 2HA6), 7.94 (d, J = 6.5 Hz, 2HB6), 7.75 (t, J = 3.1 
Hz, 2HA3), 7.72 (t, J = 2.9 Hz, 2HB3), 7.00 (dd, J = 6.5, 2.8 Hz, 2HA5), 6.72 (dd, J = 6.5, 2.7 Hz, 2HB5), 6.32 (ddd, J 
= 12.0, 9.0, 2.4 Hz, 2HC4), 6.24 (ddd, J = 11.9, 9.0, 2.4 Hz, 2HD4), 5.60 (dd, J = 9.0, 2.4 Hz, 2HD6), 5.42 (dd, J = 8.7, 
2.4 Hz, 2HC6), 4.08 – 4.05 (m, 8HCH2), 2.03 – 1.93 (m, 12HCy), 1.89 – 1.83 (m, 8HCy), 1.80 – 1.74 (m, 4HCy), 1.45 – 
1.35 (m, 8HCy), 1.29 – 1.26 (m, 4HCy), 1.25 – 1.16 (m, 8HCy); 19F NMR (376 MHz, CD2Cl2) δ (ppm) = -108.7 (d, J = 
10.1 Hz, 2F), -109.4 (d, J = 10.0 Hz, 2F), -111.0 (d, J = 10.1 Hz, 2F), -111.1 (d, J = 10.1 Hz, 2F), -140.4 (d, J = 24.5 
Hz, 2F), -143.9 (d, J = 24.0 Hz, 2F), -155.3 (t, J = 20.8 Hz, 2F), -160.5 – -160.8 (m, 2F), -162.1 – -162.4 (m, 2F); 13C 
NMR (176 MHz, CD2Cl2, TMS) δ (ppm) = 167.4 (CB2), 167.2 (CA4 or B4), 165.7 (CA2), 165.1 (CA4 or B4), 162.6 (d, J = 
255 Hz, CD5), 162.3 (d, J = 251 Hz, CC5), 160.5 (d, J = 266 Hz, CD3), 160.4 (d, J = 263 Hz, CC3), 150.1 (CA6), 148.7 
(BB6), 128. 7 (CC1), 127.15 (CD1), 114.1 (CC6), 113.6 (CD6), 109.7 (CA5), 109.6 (CB5), 108.8 (CA3), 108.4 (CB3), 97.9 
(CC4), 95.6 (CD4), 74.3 (CCH2), 74.25 (CCH2), 37.50 (CCy), 37.44 (CCy), 29.75 (CCy), 29.68 (CCy), 26.39 (CCy), 26.36 
(CCy), 25.74* (CCy), Due to low solubility in organic solvents and extensive coupling to 19F nuclei, some of the 
quaternary 13C NMR signals could not be reported.  All signals that could be clearly identified in the 13C, 1H–13C 
HSQC and 1H–13C HMBC NMR spectra are reported. The spectra are included as Figures S67, S70 and S71. MS 
(MALDI–TOF): m/z 2012.4 [M+]. Calcd. for C86H72F18Ir2N6O6+: 2012.3; Anal. Calcd. for C86H72F18Ir2N6O6+: C, 
51.34; H, 3.61; N, 4.18. Found:  C, 51.23; H, 3.60; N, 4.15. 
 
 
N,Nʹ-Bis(3,5-difluorobenzoyl)hydrazide (17a). 3,5-difluorobenzoyl chloride (16a) (5.00 g, 28.3 mmol, 2.10 eq.) 
was added dropwise under air to a stirred solution of hydrazine monohydrate (675 mg, 13.5 mmol, 1.00 eq.) in ethanol 
(10 mL), which was cooled in an ice bath to maintain the reaction temperature below 15 °C. Formation of a white 
precipitate was immediately observed. Once the addition was half complete, a further 30 mL of cold ethanol was 
added to facilitate stirring before a solution of Na2CO3 (1.50 g, 14.2 mmol, 1.05 eq.) in water (10 mL) was added 
dropwise alongside the remaining difluorobenzoyl chloride (16a). After the addition of the reagents was completed 
(ca. 20 min), the ice bath was removed and stirring was continued at room temperature for a further 30 min. The 
reaction mixture was poured into water (50 mL), allowed to settle for 1 h and filtered to collect the crude hydrazide 
as a white powder which was subsequently refluxed in ethanol (100 mL) for 10 min. The mixture was cooled to room 
temperature and then filtered to obtain N,Nʹ-bis(3,5-difluorobenzoyl)hydrazide (17a) (3.19 g, 10.2 mmol, 76%). M.pt. 
285–290 °C; 1H NMR (400 MHz, DMSO-d6) δ (ppm) = 10.84 (s, 2HN–H), 7.73 – 7.44 (m, 6H2 + 4); 13C NMR (101 
MHz, DMSO-d6) δ (ppm) = 163.7 (t, J = 2.9 Hz, CC=O), 162.8 (dd, J = 247.7, 12.7 Hz, C3), 136.1 (t, J = 8.7 Hz, C1), 
111.7 – 111.2 (m, C2), 108.1 (t, J = 25.9 Hz, C4); 19F{1H} NMR (376 MHz, DMSO-d6) δ (ppm) =  -108.3 (s, 4F); 
HRMS (ASAP): m/z 313.0607 [MH+]. Calcd. for C14H9N2O2F4+: 313.0600. 
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N,Nʹ-Bis(2,3,5,6-tetrafluorobenzoyl)hydrazide (17b). 2,3,5,6-tetrafluorobenzoyl chloride (16b) (5.00 g, 23.5 
mmol, 2.13 eq.) was added dropwise under air to a stirred solution of hydrazine monohydrate (553 mg, 11.0 mmol, 
1.00 eq.) in ethanol (10 mL), which was cooled in an ice bath to maintain the reaction temperature below 15 °C. 
Formation of a white precipitate was immediately observed. Once the addition was half complete, a solution of 
Na2CO3 (1.24 g, 11.7 mmol, 1.06 eq.) in water (10 mL) was added dropwise alongside the remaining 2,3,5,6-
tetrafluorobenzoyl chloride (16b). After the addition of the reagents was completed (ca. 20 min), the ice bath was 
removed and stirring was continued at room temperature for a further 30 min. The reaction mixture was poured into 
water (50 mL), allowed to settle for 1 h and filtered to collect the crude hydrazide as a white powder (5.30 g, 13.8 
mmol, 125%). The crude material was recrystallised twice from methanol/water and was obtained sufficiently pure 
for use in the next step (2.95 g, 7.68 mmol, 70%). M.pt. 265–269 °C; 1H NMR (400 MHz, DMSO-d6) δ (ppm) = 
11.36 (s, 2HN–H), 8.22 – 8.01 (m, 2H4); 13C NMR (101 MHz, DMSO-d6) δ (ppm) = 156.7 (CC=O), 147.2 – 141.8 (m, 
C2+3), 115.8 (t, J = 20.5 Hz, C1 or 4), 109.3 (t, J = 23.5 Hz, C1 or 4); 19F {1H} NMR (376 MHz, DMSO-d6) δ (ppm) = -
137.9 – -138.1 (m, 4F), -141.5 – -141.6 (m, 4F); HRMS (ASAP): m/z 385.0224 [MH+]. Calcd. for C14H5N2O2F8+: 
385.0223. 
 
 
N,Nʹ-Bis(pentafluorobenzoyl)hydrazide (17c). Pentafluorobenzoyl chloride (16c) (5.00 g, 21.7 mmol, 2.13 eq.) 
was cautiously added dropwise under air to a stirred solution of hydrazine monohydrate (510 mg, 10.2 mmol, 1.00 
eq.) in ethanol (10 mL), which was cooled in an ice bath to maintain the reaction temperature below 15 °C. Formation 
of a white precipitate was immediately observed. Once the addition was half complete, a further 20 mL of cold 
ethanol was added to facilitate stirring before a solution of Na2CO3 (1.15 g, 10.85 mmol, 1.06 eq.) in water (8 mL) 
was added dropwise alongside the remaining pentafluorobenzoyl chloride (16c). After the addition of the reagents 
was completed (ca. 20 min), the ice bath was removed and stirring was continued at room temperature for a further 
30 min. The reaction mixture was poured into water (50 mL), allowed to settle for 1 h and filtered to collect the crude 
hydrazide as a white powder (3.58 g, 8.57 mmol, 84%). The crude material was recrystallised twice from 
methanol/water and was obtained sufficiently pure for use in the next step (2.36 g, 5.61 mmol, 55%). M.pt. 264–266 
°C (lit. 270 °C21); 1H NMR (400 MHz, DMSO-d6) δ (ppm) = 11.41 (s, 2HN–H); 13C NMR (101 MHz, DMSO-d6) δ 
(ppm) = 156.0 (CC=O), 145.4 – 136.0 (m, C2–4), 110.5 (t, J = 21.3 Hz, C1); 19F{1H} NMR (376 MHz, DMSO-d6) δ 
(ppm) = -140.8 – -141.0 (m, 2F2 or 3), -150.9 (t, J = 22.3 Hz, 1F4), -160.6 – -160.8 (m, 2F2 or 3); HRMS (ASAP): m/z 
421.0035 [MH+]. Calcd. for C14H3N2O2F10+: 421.0035. 
 
N,Nʹ-Bis(2,3,5,6-tetrafluoro-4-methoxybenzoyl)hydrazide (17d). 2,3,5,6-Tetrafluoro-4-methoxybenzoic acid 
(16d) (1.00 g, 4.46 mmol, 1.00 eq.) was heated to reflux in SOCl2 (5 mL) with a drop of N,N-dimethylformamide 
overnight under argon. The solvent was then evaporated to obtain crude 2,3,5,6-tetrafluoro-4-methoxybenzoyl 
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chloride which was dissolved in dry chloroform (30 mL). Hydrazine monohydrate (0.1 mL, 2.09 mmol, 0.47 eq.) was 
added dropwise to the chloroform solution which was cooled in an ice bath to maintain the reaction temperature 
below 15 °C. Formation of a white precipitate was immediately observed. After the addition was completed (ca. 10 
min), the ice bath was removed and the mixture was heated to reflux for 2 h. It was then diluted with n-hexane (50 
mL), allowed to settle for 1 h and filtered to collect the crude hydrazide as a white powder (650 mg, 1.46 mmol, 70% 
based on hydrazine monohydrate). The crude material was recrystallised from ethanol and was obtained sufficiently 
pure for use in the next step (260 mg, 0.59 mmol, 28% based on hydrazine monohydrate). M.pt. 252–256 °C; 1H 
NMR (400 MHz, DMSO-d6) δ (ppm) = 11.18 (s, 2HN–H), 4.14 (s, 6HOMe); 13C NMR (101 MHz, DMSO-d6) δ (ppm) 
= 156.7 (CC=O), 145.3 – 139.0 (m, C1–3), 108.3 (t, J = 21 Hz, C4), 62.8 (COMe); 19F {1H} NMR (376 MHz, DMSO-d6) 
δ (ppm) = -142.4 – -142.5 (m, 4F), -156.9 – -157.2 (m, 4F); HRMS (ASAP): m/z 445.0422 [MH+]. Calcd. for 
C16H9N2O4F8+: 445.0435. 
 
 
Bis(trifluoromethyl)hydrazide (18). Hydrazine monohydrate (2.5 mL, 51.5 mmol, 1.00 eq.) was added to dry 
chloroform (10 mL) under argon and cooled in an ice water bath to ca. 0 °C. Trifluoroacetic anhydride (21.8 mL, 155 
mmol, 3.00 eq.) was then cautiously added to the mixture over the course of 1 h. A white precipitate immediately 
formed during the addition. Once approximately half had been added, further dry chloroform (10 mL) was added to 
facilitate stirring.  Once the addition was complete, the mixture was refluxed under argon for 1 h, before being cooled 
to room temperature and filtered. The white precipitate was washed with hexane (ca.  50 mL) to obtain 
bis(trifluoromethyl)hydrazide (18) as a white powder (9.6 g, 43 mmol, 83%). Analytical data were in agreement with 
those previously reported.22 1H NMR (400 MHz, Acetone-d6) δ (ppm) = 10.00 – 11.00 (bs, 2H); 19F {1H} NMR (376 
MHz, Acetone-d6) δ (ppm) = -75.82 (s, 6F). 
 
 
 
2-Phenyl-4-(2,4,6-trimethylphenyl)pyridine (20). 4-(2,4,6-Trimethylphenyl)-2-chloropyridine (3.36 g, 14.5 mmol, 
1.00 eq.), phenyl boronic acid (2.65 g, 21.7 mmol, 1.50 eq.) and PPh3 (912 mg, 3.48 mmol, 24 mol%) were combined in 1,4-
dioxane (45 mL). A solution of Na2CO3 (6.14 g, 57.9 mmol, 4.00 eq.) in water (10 mL) was then added and the mixture was 
degassed for 30 min. Pd(OAc)2 (195 mg, 0.87 mmol, 6 mol%) was then added and the mixture was degassed for a further 10 
minutes, before being heated to reflux under argon overnight. The mixture was then allowed to cool to room temperature and 
evaporated to near-dryness. To the residue was added water (50 mL) and DCM (50 mL). The organic layer was separated and 
the aqueous later was extracted thrice more with DCM (50 mL). The organic extracts were combined, dried over MgSO4 and 
evaporated under reduced pressure. The residue was passed through a short column of silica gel (eluent: EtOAc with ca. 0.5% 
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vol. NEt3 as an additive) before being purified by distillation on a Kugelrohr apparatus (200 °C, ca. 9 × 10-2 mbar) to afford 2-
phenyl-4-(2,4,6-trimethylphenyl)pyridine (20) as a faint yellow viscous oil (3.15 g, 11,52 mmol, 80%). Analytical data were 
in agreement with those previously reported.23 1H NMR (400 MHz, CDCl3) δ (ppm) = 8.77 (dd, J = 5.0, 0.9 Hz, 1H), 8.09 – 
8.01 (m, 2H), 7.60 (dd, J = 1.5, 0.9 Hz, 1H), 7.55 – 7.43 (m, 3H), 7.09 (dd, J = 4.9, 1.5 Hz, 1H), 7.01 (d, J = 0.7 Hz, 2H), 2.38 
(s, 3H), 2.08 (s, 6H). 
 
 
Tetrakis(2-phenyl-4-(2,4,6-trimethylphenyl)-pyridine-C2,N')(μ-dichloro)diiridium ([Ir(mesppy)2μ-Cl]2). 
IrCl3·3H2O (689 mg, 1.95 mmol, 1.00 eq.) and 2-phenyl-4(2,4,6-trimethylphenyl)-pyridine (20) (1.18 g, 4.32 mmol, 
2.21 eq.) were added to a mixture of 2-ethoxyethanol (30 mL) and water (10 mL) and heated to reflux under an argon 
atmosphere for 24 h. The reaction mixture was then cooled to room temperature and poured into water (ca. 200 mL) 
and cooled in a fridge for 1 h. The formed yellow precipitate was then isolated via filtration and washed sequentially 
with water (ca. 50 mL), cold methanol (5 mL), cold n-hexane (3 × 20 mL) and cold n-pentane (3 × 20 mL) to afford 
tetrakis(2-phenyl-4-(2,4,6-trimethylphenyl)-pyridine-C2,N')(μ-dichloro)diiridium ([Ir(mesppy)2μ-Cl]2).  as a yellow 
powder (1.42 g, 0.92 mmol, 94%). Analytical data were in agreement with those previously reported.23 1H NMR (400 
MHz, CD2Cl2) δ (ppm) = 9.70 (d, J = 5.9 Hz, 2H), 7.77 (d, J = 1.9 Hz, 2H), 7.54 (dd, J = 7.8, 1.4 Hz, 2H), 7.05 (d, J 
= 10.9 Hz, 4H), 6.89 – 6.82 (m, 4H), 6.71 (td, J = 7.5, 1.4 Hz, 2H), 5.95 (dd, J = 7.9, 1.1 Hz, 2H), 2.42 (s, 6H), 2.16 
(s, 6H), 2.15 (s, 6H). 
 
 
2-Bromo-5-(methylcyclohexyloxy)-meta-xylene (24). 2-Bromo-4-hydroxy-meta-xylene (23) (15.00 g, 74.6 mmol, 
1.00 eq.) and K2CO3 (20.6 g, 149 mmol mmol, 2.00 eq.) were combined in N,N-dimethylformamide (100 mL) and 
heated to 80 °C for 10 min under argon. Bromo(methylcyclohexane) (15.6 mL, 112 mmol, 1.50 eq.) was then added 
in a single portion and the mixture was heated to 90 °C overnight. The reaction mixture was cooled to room 
temperature and poured into water (1 L). The mixture was extracted with EtOAc/ toluene 1:1 v/v (3 × 200 mL). The 
organic layers were combined and washed with HCl (aq) (1 M, 5 × 50 mL) before being dried over MgSO4 and 
evaporated under reduced pressure to afford a brown oil. The residue was purified via flash chromatography on silica 
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gel (eluent: n-hexane). 2-Bromo-5-(methylcyclohexyloxy)-meta-xylene (24) eluted as a clear oil (21.7 g, 73.0 mmol, 
98%). 1H NMR (400 MHz, CDCl3) δ (ppm) = 6.66 (s, 2H), 3.72 (d, J = 6.4 Hz, 2H), 2.40 (S, 6H), 1.93 – 1.67 (m, 
6H), 1.39 – 1.17 (m, 3H), 1.05 (qd, J = 12.2, 3.4 Hz, 2H); 13C NMR (101 MHz, CDCl3) δ (ppm) = 157.8, 139.0, 
117.9, 114.4, 73.6, 37.7, 29.9, 26.5, 25.8, 24.0; HRMS (ASAP): m/z 296.0779 [M+]. Calcd. for C15H21OBr+: 
296.0776. 
 
 
 
 
2-Tributylstannyl-5-(methylcyclohexyloxy)-meta-xylene (25). 2-Bromo-5-(methylcyclohexyloxy)-meta-xylene 
(24) (10.5 g, 33.6 mmol, 1.00 eq.) was dissolved in dry THF (250 mL) and cooled to –78 °C under argon. t-BuLi (1.7 
M in pentane, 27 mL, 74.8 mmol, 2.22 eq.) was then added over 15 min, keeping the reaction temperature below –
65 °C. The thick yellow mixture was then stirred at –78 °C for 45 min before the addition of tributyltin chloride (11.2 
mL, 41.2 mmol, 1.23 eq.) over 5 min. The reaction was then warmed to room temperature overnight before being 
poured into hexane (200 mL). The mixture was washed with sat. NH4Cl (aq) (3 × 50 mL) before being dried over 
MgSO4, and the solvent removed under reduced pressure to afford 2-tributylstannyl-5-(methylcyclohexyloxy)-meta-
xylene (25) as a pale yellow oil (17.0 g, 33.5 mmol, 100%) which was used without further purification. 1H NMR 
(400 MHz, CDCl3) δ (ppm) = 6.59 (s + (d, 4JH–Sn = 11.7 Hz), 2H), 3.74 (d, J = 6.3 Hz, 2H), 2.38 (s + (d, 4JH–Sn = 5.5 
Hz), 6H), the aliphatic region (ca. 0.5–2 ppm) was not assigned due to the presence of alkyl tin impurities; HRMS 
(ASAP): m/z 505.2808 [MH+]. Calcd. for C27H49O116Sn+: 505.2801. 
 
 
 
2-Chloro-4-(2,6-dimethyl-4-(methylcyclohexyloxy)phenyl)pyridine (26). 2-Chloro-4-iodopyridine (3.00 g, 12.5 
mmol, 1.00 eq.), 2-tributylstannyl-5-(methylcyclohexyloxy)-meta-xylene (25) (8.74 g, 17.2 mmol, 1.38 eq.) and tri-
tert-butylphosphonium tetrafluoroborate (218 mg, 0.75 mmol, 6 mol%) were added to dry dioxane (50 mL) and the 
resulting mixture was degassed for 40 min. Pd2dba3•CHCl3 (388 mg, 0.37 mmol, 3 mol%) was then added to the 
mixture, which was degassed for a further 10 min before the addition of CsF (4.18 g, 27.5 mmol, 2.20 eq.). The red 
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reaction mixture was subsequently stirred at room temperature for 2.5 h. Analysis of an aliquot by GC-MS at this 
point indicated that the desired reaction had not occurred. Further Pd2dba3•CHCl3 (130 mg, 0.12 mmol, 1 mol%) and 
tri-tert-butylphosphonium tetrafluoroborate (73 mg, 0.25 mmol, 2 mol%) were added and the mixture was heated to 
60 °C for 17 h, after which point analysis of an aliquot by GC-MS revealed complete consumption of 2-chloro-4-
iodopyridine. The reaction mixture was cooled to room temperature, diluted with EtOAc (ca. 50 mL) and filtered 
through a plug of celite, which was subsequently washed with further EtOAc (2 × 50 mL). The combined filtrates 
were evaporated under reduced pressure and the residual crude product was purified via flash chromatography on 
silica gel (eluent: gradient EtOAc/ n-hexane 0:1–1:9 v/v with ca. 0.5% vol. NEt3 as an additive) to obtain 2-chloro-
4-(2,6-dimethyl-4-(methylcyclohexyloxy)phenyl)pyridine (26) as a brown oil (3.67 g, 11.1 mmol, 89%). Further 
purification by distillation on a Kugelrohr apparatus (ca. 110 °C, 0.1 mbar) afforded a colourless viscous oil which 
solidified upon standing (2.96 g, 8.97 mmol, 72%). M.pt. 72–75 °C; 1H NMR (400 MHz, CDCl3) δ (ppm) = 8.45 (dd, 
J = 5.0, 0.8 Hz, 1H), 7.18 (dd, J = 1.5, 0.7 Hz, 1H), 7.06 (dd, J = 5.0, 1.4 Hz, 1H), 6.68 (s, 2H), 3.78 (d, J = 6.4 Hz, 
2H), 1.93 – 1.70 (m, 6H), 1.41 – 1.19 (m, 3H), 1.15 – 1.02  (m, 2H); 13C NMR (101 MHz, CDCl3) δ (ppm) = 159.0, 
152.8, 151.8, 149.7, 136.5, 125.5, 124.1, 113.6, 73.4, 37.8, 29.9, 26.6, 25.8, 20.9; HRMS (ESI): m/z 330.1628 [MH+]. 
Calcd. for C20H25NOCl+: 330.1625. 
 
 
 
 
 
2-(2,4-Difluorophenyl)-4-(2,6-dimethyl-4-(methylcyclohexyloxy)phenyl)pyridine (21). 2-Chloro-4-(2,6-
dimethyl-4-(methylcyclohexyloxy)phenyl)pyridine (26) (617 g, 1.87 mmol, 1.00 eq.), 2,4-difluorophenyl boronic 
acid (443 mg, 2.81 mmol, 1.50 eq.) and PPh3 (20.5 mg, 0.45 mmol, 24 mol%) were combined in 1,4-dioxane (6 mL). 
A solution of Na2CO3 (795 mg, 7.48 mmol, 4.00 eq.) in water (2 mL) was then added and the mixture was degassed 
for 15 min. Pd(OAc)2 (20.5 mg, 0.11 mmol, 6 mol%) was then added and the mixture was degassed for a further 5 
minutes, before being heated to reflux under argon overnight. The mixture was then allowed to cool to room 
temperature and evaporated to near-dryness. To the residue was added water (30 mL) and DCM (40 mL). The organic 
layer was separated and the aqueous later was extracted twice more with DCM (40 mL). The organic extracts were 
combined, dried over MgSO4 and evaporated under reduced pressure. The residue was purified by flash 
chromatography on silica gel (eluent: gradient EtOAc/ n- hexane 1:99–1:9 v/v with ca. 0.5% vol. NEt3 as an additive). 
2-(2,4-Difluorophenyl)-4-(2,6-dimethyl-4-(methylcyclohexyloxy)phenyl)pyridine (21) was obtained as a white tacky 
solid (678g, 1.66 mmol, 90%). M.pt. 117–118 °C; 1H NMR (600 MHz, CDCl3) δ (ppm) = 8.74 (dd, J = 5.0, 0.9 Hz, 
1HA6), 8.07 (td, J = 8.8, 6.6 Hz, 1HB6), 7.57 (dd, J = 1.5, 0.9 Hz, 1HA3), 7.07 (dd, J = 5.0, 1.5 Hz, 1HA5), 7.02 (dddd, 
J = 8.8, 7.9, 2.6, 1.4 Hz, 1HB5), 6.90 (ddd, J = 11.3, 8.8, 2.6 Hz, 1HB3), 6.68 (s, 2HC2), 3.77 (d, J = 6.4 Hz, 2HCH2Cy), 
2.06 (s, 6HCMe), 1.92 – 1.85 (m, 2HCyH2e), 1.85 – 1.81 (m, 1HCyH1), 1.77 (dt, J = 13.0, 3.4 Hz, 2HCyH3e), 1.74 – 1.68 
(m, 1HCyH4e), 1.32 (qt, J = 12.6, 3.4 Hz, 2HCyH3a), 1.22 (qt, J = 12.7, 3.4 Hz, 1HCyH4a), 1.07 (qd, J = 12.4, 3.5 Hz, 
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2HCyH2a); 13C NMR (151 MHz, CDCl3) δ (ppm) = 163.2 (dd, J = 250.9, 12.0 Hz, CB4), 160.6 (dd, J = 252.8, 12.0 Hz, 
CB2), 158.7 (CC1), 152.6 (d, J = 2.6 Hz, CA2), 149.9 (CA4), 149.8 (CA6), 136.7 (CC3), 132.2 (dd, J = 9.7, 4.4 Hz, CB6), 
131.4 (CC4), 125.7 (d, J = 9.4 Hz, CA3), 123.9 (CA5), 123.9 (dd, J = 12.0, 3,9 Hz, CB1), 113.5 (CC2), 111.9 (dd, J = 
21.1, 3.6 Hz, CB5), 104.4 (dd, J = 27.0, 25.3 Hz, CB3), 73.4 (CCH2), 37.7 (CCy1), 29.9 (CCy2), 26.5 (CCy4), 25.8 (CCy3), 
21.0 (CMe); 19F {1H} NMR (376 MHz, CDCl3) δ (ppm) = -109.2 – -109.5 (m, 1F), -112.7 – - 112.8 (m, 1F); HRMS 
(ESI): m/z 408.2128 [MH+]. Calcd. for C26H28NOF2+: 408.2139.  
 
 
 
 
 
4-(Methylcyclohexyloxy)-2-chloropyridine (28). 2-Chloro-4-pyridone (27) (5.00 g, 38.6 mmol, 1.00 eq.) and 
K2CO3 (10.7 g, 77.2 mmol, 2.00 eq.) were combined in N,N-dimethylformamide (50 mL) and heated to 80 °C for 10 
min under argon. Bromo(methylcyclohexane) (8.1 mL, 57.9 mmol, 1.50 eq.) was then added in a single portion and 
the mixture was heated to 90 °C for a further 4 h. The reaction mixture was cooled to room temperature and poured 
into water (200 mL). The mixture was extracted with EtOAc/ toluene 1:1 v/v (4 × 100 mL). The organic layers were 
combined and washed with HCl (aq) (1 M, 5 × 50 mL) before being dried over MgSO4 and evaporated under reduced 
pressure to afford a brown oil. The residue was purified via flash chromatography on silica gel (eluent: EtOAc/ n-
hexane 3:7 v/v) to obtain 4-(methylcyclohexyloxy)-2-chloropyridine (28) as a waxy white solid (7.55 g, 33.4 mmol, 
87%). M.pt. 54–55 °C; 1H NMR (400 MHz, CDCl3) δ (ppm) = 8.19 (d, J = 5.8 Hz, 1H), 6.84 (d, J = 2.2 Hz, 1H), 
6.75 (dd, J = 5.8, 2.3 Hz, 1H), 3.81 (d, J = 6.1 Hz, 2H), 1.93 – 1.59 (m, 6H), 1.40 – 1.15 (m, 3H), 1.14 – 0.99 (m, 
2H);  13C NMR (101 MHz, CDCl3) δ (ppm) = 167.0, 152.5, 150.1, 110.1, 109.9, 73.9, 37.3, 29.7, 26.3, 25.7; HRMS 
(ESI): m/z 226.1001 [MH+]. Calcd. for C12H17NOCl+: 226.0999.  
 
 
 
2-(2,4-Difluorophenyl)-4-(methylcyclohexyloxy)pyridine (22). 4-(Methylcyclohexyloxy)-2-chloropyridine (28) 
(2.00 g, 8.86 mmol, 1.00 eq.), 2,4-difluorophenyl boronic acid (2.10 g, 13.29 mmol, 1.50 eq.) and PPh3 (558 mg, 2.13 
mmol, 24 mol%) were combined in 1,4-dioxane (32 mL). A solution of Na2CO3 (3.76 g, 35.4 mmol, 4.00 eq.) in 
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water (12 mL) was then added and the mixture was degassed for 30 min. Pd(OAc)2 (120 mg, 0.53 mmol, 6 mol%) 
was then added and the mixture was degassed for a further 10 min, before being heated to reflux under argon 
overnight. The mixture was then allowed to cool to room temperature and evaporated to near-dryness. To the residue 
was added water (50 mL) and DCM (50 mL). The organic layer was separated and the aqueous later was extracted 
twice more with DCM (50 mL). The organic extracts were combined, dried over MgSO4 and evaporated under 
reduced pressure. The residue was purified by flash chromatography on silica gel (eluent: EtOAc/ n- hexane 4:6 v/v 
with ca. 0.5% vol. NEt3 as an additive). 2-(2,4-Difluorophenyl)-4-(methylcyclohexyloxy)pyridine (22) was obtained 
as a faint yellow oil  which solidified on standing (2.68 g, 8.83 mmol, 100%). M.pt. 66–68 °C; 1H NMR (600 MHz, 
CDCl3) δ (ppm) = 8.49 (d, J = 5.7 Hz, 1HA6), 7.97 (td, J = 8.8, 6.6 Hz, 1HB6), 7.24 (ap. t, J = 2.4 Hz, 1HA3), 6.98 
(tdd, J = 7.8, 2.5, 1.0 Hz, 1HB5), 6.90 (ddd, J = 11.3, 8.8, 2.5 Hz, 1HB3), 6.77 (dd, J = 5.7, 2.4 Hz, 1HA5), 3.84 (d, J = 
6.3 Hz, 2HCH2Cy), 1.89 – 1.85 (m, 2HCyH2e), 1.84 – 1.81 (m, 1HCyH1), 1.78 (dt, J = 12.9, 3.4 Hz, 2HCyH3e), 1.73 – 1.69 
(m, 1HCyH4e), 1.31 (qt, J = 12.7, 3.4 Hz, 2HCyH3a), 1.21 (qt, J = 12.8, 3.4 Hz, 1HCyH4a), 1.07 (qd, J = 12.7, 3.6 Hz, 
2HCyH2a); 13C NMR (151 MHz, CDCl3) δ (ppm) = 165.7 (CA4), 163.08 (dd, J = 250.7, 12.1 Hz, CB4), 160.45 (dd, J = 
252.4, 11.9 Hz, CB2), 153.9 (d, J = 2.4 Hz, CA2), 150.7 (CA6), 132.1 (dd, J = 9.6, 4.5 Hz, CB6), 123.9 (dd, J = 11.6, 
3.8 Hz, CB1), 111.7 (dd, J = 21.0, 3.7 Hz, CB5), 110.9 (d, J = 9.1 Hz, CA3), 109.0 (CA5), 104.3 (dd, J = 27.1, 25.3 Hz, 
CB3), 73.4 (CCH2), 37.4 (CCy1), 29.8 (CCy2), 26.4 (CCy4), 25.7 (CCy3); 19F{1H} NMR (376 MHz, CDCl3) δ (ppm) = -
109.4 (d, J = 8.5 Hz, 1F), -112.7 (d, J = 8.5 Hz, 1F); HRMS (ESI): m/z 304.1517 [MH+]. Calcd. for C18H20NOF2+: 
304.1513. 
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Copies of NMR Spectra 
 
Figure S1. 1H NMR spectrum (600 MHz) of 7 in CD2Cl2 (TMS). 
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Figure S2. 19F{1H} NMR spectrum (376 MHz) of 7 in CD2Cl2. 
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Figure S3. Expansion of the aromatic region of the 1H–1H COSY NMR spectrum of 7 in CD2Cl2 (TMS).   
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Figure S4. 1H NMR spectrum (600 MHz) of 8 in CD2Cl2 (TMS). 
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Figure S5. 19F{1H} NMR spectrum (376 MHz) of 8 in CD2Cl2. 
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Figure S6. Expansion of the aromatic region of the 1H–1H COSY NMR spectrum of 8 in CD2Cl2 (TMS). 
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Figure S7. 1H NMR spectrum (700 MHz) of 9 in CD2Cl2 (TMS).  
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Figure S8. 13C NMR spectrum (151 MHz) of 9 in CD2Cl2 (TMS). 
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Figure S9. 19F{1H} NMR spectrum (376 MHz) of 9 in CD2Cl2. 
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Figure S10. Expansion of the aromatic region of the 1H–1H COSY NMR spectrum of 9 in CD2Cl2 (TMS). 
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Figure S11. 1H–13C HSQC NMR spectrum of 9 in CD2Cl2. 
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Figure S12. 1H–13C HMBC NMR spectrum of 9 in CD2Cl2. 
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Figure S13. Aromatic region of the 1H–1H NOESY NMR spectrum of 9 in CD2Cl2. 
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Figure S14. 1H NMR spectrum (700 MHz) of meso 9 in CD2Cl2.* = Peaks from residual toluene. 
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Figure S15. 19F{1H} NMR spectrum (376 MHz) of meso 9 in CD2Cl2. 
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Figure S16. 1H NMR spectrum (600 MHz) of 10 in CD2Cl2 (TMS). 
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Figure S17. 13C NMR spectrum (151 MHz) of 10 in CD2Cl2 (TMS). 
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Figure S18. 19F{1H} NMR spectrum (376 MHz) of 10 in CD2Cl2. 
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Figure S19. Expansion of the aromatic region of the 1H–1H COSY NMR spectrum of 10 in CD2Cl2 (TMS). 
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Figure S20. 1H–13C HSQC NMR spectrum of 10 in CD2Cl2. 
S43 
 
 
Figure S21. 1H–13C HMBC NMR spectrum of 10 in CD2Cl2. 
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Figure S22. 1H NMR spectrum (700 MHz) of rac 11 in CD2Cl2 (TMS). 
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Figure S23. 13C NMR spectrum (151 MHz) of rac 11 in CD2Cl2 (TMS). 
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Figure S24. 19F{1H} NMR spectrum (376 MHz) of rac 11 in CD2Cl2 
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Figure S25. 19F–19F COSY NMR spectrum of rac 11 in CD2Cl2. 
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Figure S26. 1H–1H COSY NMR spectrum of rac 11 in CD2Cl2 (TMS). 
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Figure S27. Expansion of the aromatic region of the 1H–1H COSY NMR spectrum of rac 11 in CD2Cl2 (TMS). 
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Figure S28. 1H–13C HSQC NMR spectrum of rac 11 in CD2Cl2 (TMS). 
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Figure S29. 1H–13C HMBC NMR spectrum of rac 11 in CD2Cl2 (TMS). 
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Figure S30. 1H–1H NOESY NMR spectrum of rac 11 in CD2Cl2 (TMS). 
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Figure S31. 1H NMR spectrum (700 MHz) of meso 12 in THF-d8. 
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Figure S32. 13C NMR spectrum (151 MHz) of meso 12 in THF-d8. 
S55 
 
 
 
 
Figure S33. 19F{1H} NMR spectrum (376 MHz) of meso 12 in THF-d8. 
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Figure S34. 1H–1H COSY NMR spectrum of meso 12 in THF-d8. 
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Figure S35. Expansion of the aromatic region of the 1H–1H COSY NMR spectrum of meso 12 in THF-d8. 
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Figure S36. 1H–13C HSQC NMR spectrum of meso 12 in THF-d8. 
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Figure S37. 1H–13C HMBC NMR spectrum of meso 12 in THF-d8. 
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Figure S38. 1H–1H NOESY NMR spectrum of meso 12 in THF-d8. 
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Figure S39. 1H NMR spectrum (400 MHz) of the µ–dichloro dimer isolated as an intermediate in the synthesis of complex 13 in CD2Cl2 (TMS).  
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Figure S40. 1H NMR spectrum (600 MHz) of meso 13 in CD2Cl2. 
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Figure S41. 13C NMR spectrum (151 MHz) of meso 13 in CD2Cl2. 
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Figure S42. 19F{1H} NMR spectrum (376 MHz) of meso 13 in CD2Cl2. 
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Figure S43. 1H–1H COSY NMR spectrum of meso 13 in CD2Cl2. 
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Figure S44. Expansion of the aromatic region of the 1H–1H COSY NMR spectrum of meso 13 in CD2Cl2. 
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Figure S45. 1H–13C HSQC NMR spectrum of meso 13 in CD2Cl2. 
S68 
 
 
Figure S46. 1H–13C HMBC NMR spectrum of meso 13 in CD2Cl2. 
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Figure S47. 1H–1H NOESY NMR spectrum of meso 13 in CD2Cl2. 
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Figure S48. 1H–1H ROESY NMR spectrum of meso 13 in CD2Cl2. 
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Figure S49. 1H NMR spectrum (700 MHz) of rac 13 in CD2Cl2 (TMS). 
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Figure S50. 13C NMR spectrum (151 MHz) of rac 13 in CD2Cl2 (TMS). 
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Figure S51. 19F{1H} NMR spectrum (376 MHz) of rac 13 in CD2Cl2. 
S74 
 
 
Figure S52. 1H–1H COSY NMR spectrum of rac 13 in CD2Cl2 (TMS). 
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Figure S53. Expansion of the aromatic region of the 1H–1H COSY NMR spectrum of rac 13 in CD2Cl2 (TMS). 
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Figure S54. 1H–13C HSQC NMR spectrum of rac 13 in CD2Cl2 (TMS). 
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Figure S55. 1H–13C HMBC NMR spectrum of rac 13 in CD2Cl2 (TMS). 
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Figure S56. 1H–1H NOESY NMR spectrum of rac 13 in CD2Cl2 (TMS). 
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Figure S57. 1H NMR spectrum (700 MHz) of 14 in CD2Cl2 (TMS). 
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Figure S58. 13C NMR spectrum (151 MHz) of 14 in CD2Cl2 (TMS). 
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Figure S59. 19F{1H} NMR spectrum (376 MHz) of 14 in CD2Cl2. 
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Figure S60. 1H–1H COSY NMR spectrum of 14 in CD2Cl2 (TMS). 
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Figure S61. Expansion of the aromatic region of the 1H–1H COSY NMR spectrum of 14 in CD2Cl2 (TMS). 
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Figure S62. 1H–13C HSQC NMR spectrum of 14 in CD2Cl2 (TMS). 
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Figure S63. 1H–13C HMBC NMR spectrum of 14 in CD2Cl2 (TMS). 
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Figure S64. 1H–1H NOESY NMR spectrum of 14 in CD2Cl2 (TMS). 
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Figure S65. 1H NMR spectrum (400 MHz) of the µ–dichloro dimer isolated as an intermediate in the synthesis of complex 15 in CD2Cl2 (TMS).  
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Figure S66. 1H NMR spectrum (700 MHz) of 15 in CD2Cl2 (TMS). 
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Figure S67. 13C NMR spectrum (151 MHz) of 15 in CD2Cl2 (TMS). 
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Figure S68. 19F{1H} NMR spectrum (376 MHz) of 15 in CD2Cl2. 
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Figure S69. Expansion of the aromatic region of the 1H–1H COSY NMR spectrum of 15 in CD2Cl2 (TMS). 
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Figure S70. 1H–13C HSQC NMR spectrum of 15 in CD2Cl2 (TMS). 
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Figure S71. 1H–13C HMBC NMR spectrum of 15 in CD2Cl2 (TMS). 
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Figure S72. 1H NMR spectrum (400 MHz) of 17a in DMSO-d6. 
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Figure S73. 13C NMR spectrum (101 MHz) of 17a in DMSO-d6. 
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Figure S74. 19F{1H} NMR spectrum (376 MHz) of 17a in DMSO-d6. 
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Figure S75. 1H NMR spectrum (400 MHz) of 17b in DMSO-d6. 
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Figure S76. 13C NMR spectrum (101 MHz) of 17b in DMSO-d6. 
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Figure S77. 19F{1H} NMR spectrum (376 MHz) of 17b in DMSO-d6. 
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Figure S78. 1H NMR spectrum (400 MHz) of 17c in DMSO-d6. 
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Figure S79. 13C NMR spectrum (101 MHz) of 17c in DMSO-d6. 
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Figure S80. 19F{1H} NMR spectrum (376 MHz) of 17c in DMSO-d6. 
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Figure S81. 1H NMR spectrum (400 MHz) of 17d in DMSO-d6. 
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Figure S82. 13C NMR spectrum (101 MHz) of 17d in DMSO-d6. 
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Figure S83. 19F{1H} NMR spectrum (376 MHz) of 17d in DMSO-d6. 
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Figure S84. 1H NMR spectrum (400 MHz) of 24 in CDCl3. 
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Figure S85. 13C NMR spectrum (101 MHz) of 24 in CDCl3. 
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Figure S86. 1H NMR spectrum (400 MHz) of 25 in CDCl3. 
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Figure S87. 1H NMR spectrum (400 MHz) of 26 in CDCl3. 
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Figure S88. 13C NMR spectrum (101 MHz) of 26 in CDCl3. 
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Figure S89. 1H NMR spectrum (600 MHz) of 21 in CDCl3. 
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Figure S90. 13C NMR spectrum (151 MHz) of 21 in CDCl3. 
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Figure S91. 19F{1H} NMR spectrum (376 MHz) of 22 in CDCl3. 
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Figure S92. 1H NMR spectrum (400 MHz) of 28 in CDCl3. 
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Figure S93. 13C NMR spectrum (101 MHz) of 28 in CDCl3. 
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Figure S94. 1H NMR spectrum (600 MHz) of 22 in CDCl3. 
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Figure S95. 13C NMR spectrum (151 MHz) of 22 in CDCl3. 
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Figure S96. 19F{1H} NMR spectrum (376 MHz) of 22 in CDCl3 
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X–ray Crystallography         
Table S1. Selected geometrical parameters of diiridium complexes (bond distances averaged, in Å). 
CCDC numbers are as follows: 7 3CH2Cl2 = 1576081, 9 = 1576082, α-10 = 1576083, β-10 = 1576084, 11 2CH2Cl2 = 
1576093, 12 5CH2Cl2 = 1576094, 13 2.25CD2Cl2 = 1576095. 
 7 3CH2Cl2 9 α-10 β-10 11 2CH2Cl2 12 5CH2Cl2a 13 2.25CD2Cl2 
Space group P1̅ I41/a C2/c P21/n P1̅ P1̅ P1̅ 
Molec. symm Ci Ci C2 -- -- Ci -- 
Ir centres ΔΛ ΔΛ ΔΔ, ΛΛ ΔΔ, ΛΛ ΔΔ, ΛΛ ΔΛ ΔΔ, ΛΛ 
Ir…Ir, Å 5.091 5.089 5.117 5.062 5.082 5.147, 5.152 5.070 
Ir–C (trans-O) 1.998(2) 2.006(6) 2.001(2) 1.994(4) 1.992(7) 1.994(3) 1.988(4) 
Ir–C (trans-N) 2.001(2) 1.994(6) 1.997(2) 2.002(4) 2.000(7) 1.992(3) 1.996(4) 
Ir–N, stacked 2.032(2) 2.005(6) 2.040(1) 2.033(3) 2.033(5) 2.029(3) 2.035(3) 
Ir–N, non-stacked 2.042(2) 1.973(6) 2.044(1) 2.031(3) 2.037(5) 2.042(3) 2.031(3) 
OCNNCO folding, ° planar planar 6.8 24.3 14.3 planar 17.9 
Ir displacement, Å 0.01 0.23 0.06 0.28, 0.39 0.26, 0.20 0.52, 0.00 0.17, 0.24 
Ir–O 2.152(2) 2.161(2) 2.156(1) 2.147(3) 2.142(5) 2.144(2) 2.127(3) 
Ir–N 2.171(2) 2.170(3) 2.180(1) 2.164(3) 2.169(5) 2.214(2) 2.175(3) 
N–N 1.438(3) 1.435(5) 1.439(2) 1.443(4) 1.448(6) 1.445(2) 1.436(4) 
N–C 1.312(3) 1.308(4) 1.314(2) 1.307(5) 1.305(8) 1.310(4) 1.301(5) 
C–O 1.286(2) 1.279(4) 1.283(2) 1.275(4) 1.279(8) 1.268(4) 1.278(4) 
Θ, ºb 8.5 5.9 13.5 6.9, 8.7  4.6, 6.0 -- 6.2, 3.4 
D, Åc 3.32 3.24 3.42 3.39, 3.35 3.33, 3.30 -- 3.27, 3.19 
a contains two crystallographically non-equivalent centrosymmetric dimers; b interplanar angle between ring A of the 
bridging ligand and ring B of the cyclometalating ligand (see Figure 4); c distance between the plane of ring B and the 
centroid of ring A. 
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Figure S97. X-ray molecular structure of rac 13. Thermal ellipsoids are drawn at 50% probability level. H atoms are omitted 
for clarity. 
 
 
 
Figure S98. Molecular structure of meso 7 viewed perpendicular to the plane of the cyclometalating phenyl moieties to 
highlight intramolecular π–π interactions. The bridge (A) and cyclometalating ligand (B) phenyl groups that are engaged in 
intramolecular π–π stacking are labelled (see Table S1). 
A 
A B 
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S121 
 
 
Figure S99. Molecular structure of meso 9 viewed perpendicular to the plane of the cyclometalating phenyl moieties to 
highlight intramolecular π–π interactions. The bridge (A) and cyclometalating ligand (B) phenyl groups that are engaged in 
intramolecular π–π stacking are labelled (see Table S1). 
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Figure S100. Molecular structures of α-ΔΔ 10 (top) and β-ΔΔ 10 (bottom) viewed perpendicular to the plane of the 
cyclometalating phenyl moieties to highlight intramolecular π–π interactions. The bridge (A) and cyclometalating ligand (B) 
phenyl groups that are engaged in intramolecular π–π stacking are labelled (see Table S1). 
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Figure S101. Molecular structure of ΔΔ 11 viewed perpendicular to the plane of the cyclometalating phenyl moieties to 
highlight intramolecular π–π interactions. The bridge (A) and cyclometalating ligand (B) phenyl groups that are engaged in 
intramolecular π–π stacking are labelled (see Table S1). 
 
 
Figure S102. Molecular structures of molecule A (left) and molecule B (right) of meso 12 viewed perpendicular to the plane 
of the cyclometalating phenyl moieties. 
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Figure S103. Molecular structure of ΔΔ 13 viewed perpendicular to the plane of the cyclometalating phenyl moieties to 
highlight intramolecular π–π interactions. The bridge (A) and cyclometalating ligand (B) phenyl groups that are engaged in 
intramolecular π–π stacking are labelled (see Table S1). 
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Electrochemistry  
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Figure S104. Cyclic voltammogram in 0.1 M n-Bu4PF6/ DCM showing the oxidation processes for complex 7. 
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Figure S105. Cyclic voltammogram in 0.1 M n-Bu4PF6/ DCM showing the oxidation processes for complex 8. 
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Figure S106. Cyclic voltammogram in 0.1 M n-Bu4PF6/ DCM showing the oxidation processes for complex 9. 
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Figure S107. Cyclic voltammogram in 0.1 M n-Bu4PF6/ DCM showing the oxidation processes for complex 10.
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Figure S108. Cyclic voltammogram in 0.1 M n-Bu4PF6/ DCM showing the oxidation processes for complex 11.
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Figure S109. Cyclic voltammogram in 0.1 M n-Bu4PF6/ DCM showing the oxidation processes for complex 12.
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Figure S110. Cyclic voltammogram in 0.1 M n-Bu4PF6/ DCM showing the oxidation processes for complex meso 
13.  
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Figure S111. Cyclic voltammogram in 0.1 M n-Bu4PF6/ DCM showing the oxidation processes for complex rac 13.
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Figure S112. Cyclic voltammogram in 0.1 M n-Bu4PF6/ DCM showing the oxidation processes for complex 14.
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Figure S113. Cyclic voltammogram in 0.1 M n-Bu4PF6/ DCM showing the oxidation processes for complex 15.
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Figure S114. Cyclic voltammograms in 0.1 M n-Bu4PF6/ DCM showing the oxidation processes for complex 11 over 
10 consecutive scans. The potential axis is arbitrary due to the absence of internal ferrocene. The oxidation potentials 
slightly drift due to the use of a quasireference electrode. 
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Figure S115. Cyclic voltammograms in 0.1 M n-Bu4PF6/ DCM showing the oxidation processes for complex 15 over 
10 consecutive scans. The potential axis is arbitrary due to the absence of internal ferrocene. The oxidation potentials 
slightly drift due to the use of a quasireference electrode. 
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Figure S116. Cyclic voltammogram in 0.1 M n-Bu4PF6/ THF showing the reduction process for complex 7. 
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Figure S117. Cyclic voltammogram in 0.1 M n-Bu4PF6/ THF showing the reduction process for complex 8. 
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Figure S118. Cyclic voltammogram in 0.1 M n-Bu4PF6/ THF showing the reduction process for complex 9. 
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Figure S119. Cyclic voltammogram in 0.1 M n-Bu4PF6/ THF showing the reduction process for complex 10. 
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Figure S120. Cyclic voltammogram in 0.1 M n-Bu4PF6/ THF showing the reduction process for complex rac 11. 
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Figure S121. Cyclic voltammogram in 0.1 M n-Bu4PF6/ THF showing the reduction process for complex meso 12. 
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Figure S122. Cyclic voltammogram in 0.1 M n-Bu4PF6/ THF showing the reduction process for complex meso 13. 
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Figure S123. Cyclic voltammogram in 0.1 M n-Bu4PF6/ THF showing the reduction process for complex rac 13. 
 
 
S135 
 
-3500 -3000 -2500 -2000 -1500 -1000 -500
C
u
rr
e
n
t 
(a
.u
.)
Potential vs. FcH/ FcH+ (mV)
 
Figure S124. Cyclic voltammogram in 0.1 M n-Bu4PF6/ THF showing the reduction process for complex 14. 
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Figure S125. Cyclic voltammogram in 0.1 M n-Bu4PF6/ THF showing the reduction process for complex 15. 
 
 
S136 
 
 
Computations 
Table S2 Summary of the HOMO compositions for the most stable minima of the rac and meso diastereomers of the 
complexes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The atom/ group contributions are stated as percentages. aPhenyl moieties of the cyclometalating ligands bPyridyl 
moieties of the cyclometalating ligands. 
 
 
Complex Isomer Ir Bridge centre Bridge aryl Pha Pyb 
7 
meso 42 28 1 23 6 
rac 38 41 2 14 5 
8 
meso 45 18 1 31 5 
rac 48 4 0 42 6 
9 
meso 45 16 1 33 5 
rac 48 4 0 42 6 
10 
meso 45 20 1 29 5 
rac 40 44 2 9 5 
11 
meso 44 22 1 28 6 
rac 47 4 0 42 6 
12 
meso 45 4 - 46 6 
rac 45 3 - 46 6 
13 
meso 42 35 1 15 5 
rac 40 44 2 8 6 
14 
meso 45 4 - 44 7 
rac 45 4 - 44 7 
15 
meso 42 42 1 9 6 
rac 42 46 1 4 7 
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Figure S126. Frontier molecular orbitals for the most stable minimum of meso 7 
 
 
 
 
 
 
 
LUMO 
 
–1.50 eV 
 
Ir : Bridge : F2
 
: Ph : Py 
 
45 : Br26ge : 1
5 
: 21 : 72o 
HOMO 
 
–4.95 eV 
 
Ir : Bridge : F2: Ph : Py 
 
42 : Br28ge : 1
5 
: 23 : 68o 
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Figure S127. Frontier molecular orbitals for the most stable minimum of  rac 7 
 
 
 
 
 
 
 
 
 
LUMO 
 
–1.47 eV 
 
Ir : Bridge : F2: Ph : Py 
 
45 : Br16ge : 1 : 22 : 70o 
HOMO 
 
–4.92 eV 
 
Ir : Bridge : F2
 
: Ph : Py 
 
38 : Br41ge : 2
5 
: 14 : 50o 
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Figure S128. Frontier molecular orbitals for the most stable minimum of meso 8 
 
 
 
 
 
 
 
 
 
LUMO 
 
–1.46 eV 
 
Ir : Bridge : F4
 
: Ph : Py 
 
45 : Br18ge : 1
5 
: 23 : 71o 
HOMO 
 
–4.95 eV 
 
Ir : Bridge : F4
 
: Ph : Py 
 
45 : Br18ge : 1
5 
: 31 : 58o 
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Figure S129. Frontier molecular orbitals for the most stable minimum of rac 8 
LUMO 
 
–1.43 eV 
 
Ir : Bridge : F4
 
: Ph : Py 
 
44 : Br26ge : 4
5 
: 22 : 68o 
HOMO 
 
–4.97 eV 
 
Ir : Bridge : F4
 
: Ph : Py 
 
48 : Br46ge : 0
5 
: 42 : 60o 
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Figure S130. Frontier molecular orbitals for the most stable minimum of meso 9 
 
 
 
 
 
 
 
 
 
LUMO 
 
–1.56 eV 
 
Ir : Bridge : F5
 
: Ph : Py 
 
45 : Br16ge : 1
5 
: 23 : 70o 
HOMO 
 
–5.06 eV 
 
Ir : Bridge : F5
 
: Ph : Py 
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: 33 : 50o 
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Figure S131. Frontier molecular orbitals for the most stable minimum of rac 9 
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Ir : Bridge : F5
 
: Ph : Py 
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5 
: 22 : 68o 
HOMO 
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: Ph : Py 
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Figure S132. Frontier molecular orbitals for the most stable minimum of meso 10 
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Figure S133. Frontier molecular orbitals for the most stable minimum of rac 10 
 
 
 
 
 
 
 
 
LUMO 
 
–1.38 eV 
 
Ir : Bridge : F4 : Ph : Py 
 
44 : Br16ge : 1
5 
: 24 : 70o 
HOMO 
 
–4.91 eV 
 
Ir : Bridge : F4
 
: Ph : Py 
 
40 : Br44ge : 2
5 
: 92 : 50o 
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Figure S134. Frontier molecular orbitals for the most stable minimum of meso 11 
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Ir : Bridge : F5
 
: Ph : Py 
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: 22 : 67o 
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Ir : Bridge : F5
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5 
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Figure S135. Frontier molecular orbitals for the most stable minimum of rac 11 
LUMO 
 
–1.46 eV 
 
Ir : Bridge : F5
 
: Ph : Py 
 
44 : Br36ge : 6
5 
: 21 : 64o 
HOMO 
 
–5.02 eV 
 
Ir : Bridge : F5: Ph : Py 
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Figure S136. Frontier molecular orbitals for the most stable minimum of meso 12 
LUMO 
 
–1.42 eV 
 
Ir : Bridge : Ph : Py 
 
44 : Br26ge : 21 : 69o 
HOMO 
 
–4.98 eV 
 
Ir : Bridge : Ph : Py 
 
45 : Br46ge : 46 : 60o 
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Figure S137. Frontier molecular orbitals for the most stable minimum of rac 12 
LUMO 
 
–1.44 eV 
 
Ir : Bridge : Ph : Py 
 
44 : Br26ge : 21 : 71o 
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–4.97 eV 
 
Ir : Bridge : Ph : Py 
 
45 : Br36ge : 46 : 60o 
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Figure S138. Frontier molecular orbitals for the most stable minimum of meso 13 
LUMO 
 
–1.73 eV 
 
Ir : Bridge : F5
 
: Ph : Py 
 
45 : Br16ge : 2
5 
: 20 : 66o 
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–5.44 eV 
 
Ir : Bridge : F5
 
: Ph : Py 
 
42 : Br35ge : 1
5 
: 15 : 50o 
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Figure S139. Frontier molecular orbitals for the most stable minimum of rac 13 
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–1.73 eV 
 
Ir : Bridge : F5
 
: Ph : Py 
 
44 : Br46ge : 9
5 
: 21 : 61o 
HOMO 
 
–5.47 eV 
 
Ir : Bridge : F5
 
: Ph : Py 
 
40 : Br44ge : 2
5 
: 82 : 60o 
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Figure S140. Frontier molecular orbitals for the most stable minimum of meso 14 
LUMO 
 
–1.71 eV 
 
Ir : Bridge : Ph : Py 
 
44 : Br26ge : 22 : 68o 
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–5.53 eV 
 
Ir : Bridge : Ph : Py 
 
45 : Br46ge : 44 : 70o 
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Figure S141. Frontier molecular orbitals for the most stable minimum of rac 14 
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–1.72 eV 
 
Ir : Bridge : Ph : Py 
 
44 : Br26ge : 22 : 70o 
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–5.53 eV 
 
Ir : Bridge : Ph : Py 
 
45 : Br46ge : 44 : 70o 
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Figure S142. Frontier molecular orbitals for the most stable minimum of meso 15 
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Figure S143. Frontier molecular orbitals for the most stable minimum of rac 15 
LUMO 
 
–1.50 eV 
 
Ir : Bridge : F5
 
: Ph : Py 
 
43 : Br86ge : 17
 
: 23 : 48o 
HOMO 
 
–5.34 eV 
 
Ir : Bridge : F5
 
: Ph : Py 
 
42 : Br46ge : 1
5 
: 45 : 70o 
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Thermal analysis 
  
Figure S144. TGA trace of complex 7. Onset = 371 °C. 
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Figure S145. TGA trace of complex 8. Onset = 377 °C. 
S157 
 
 
Figure S146. TGA trace of complex 9. Onset = 387 °C. 
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Figure S147. TGA trace of complex 10. Onset = 386 °C. 
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Figure S148. TGA trace of complex 11. Onset = 374 °C. 
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Figure S149. TGA trace of complex 12. Onset = 440 °C. 
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Figure S150. TGA trace of complex meso 13. Onset = 463 °C. 
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Figure S151. TGA trace of complex rac 13. Onset = 428 °C. 
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Figure S152. TGA trace of complex 14. Onset = 420 °C. 
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Figure S153. TGA trace of complex 15. Onset > 450 °C. 
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Photophysics  
 
Table S3. Tabulated absorption data for complexes 7–15 recorded in room temperature DCM solutions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
aValues taken from ref 17. *Single diastereomer of unknown absolute configuration. sh = shoulder 
 
 
 
Figure S154. Absorption spectra of complexes 7–15 recorded in room temperature DCM solutions. Insets are 
expansions of the 350–500 nm regions.  
 
  
Complex Isomer λabs /nm (ε × 103 / M–1cm–1) 
7 mixture 263 (77), 285sh (52), 310sh (30), 352 (15), 408 (7.5), 460 (4.3) 
8 mixture 262 (70), 305sh (32), 345 (14), 380 (8.3), 400 (7.5), 455 (3.9) 
9 mixture 261 (66), 281sh (50), 303sh (33), 345 (14), 400 (7.2), 453 (3.9) 
10 mixture 262 (66), 281sh (50), 305sh (30), 347 (13), 377 (7.7), 401 (7.0), 451 (3.7) 
11 rac 264 (80), 282 (70), 348 (19), 381 (11), 404 (10), 455 (5.5) 
12 meso 265 (87), 281sh (81), 343 (25), 400 (11), 452 (5.4) 
13 
meso 255 (96), 274sh (79), 305sh (51), 336 (36), 384 (14), 430 (4.2), 460 (1.7) 
rac 255 (94), 276sh (73), 205sh (51), 335 (35), 386 (14), 430 (4.4), 460 (1.7) 
14 * 252 (89), 272sh (77), 312sh (46), 331 (38), 382 (12), 429 (2.5), 457 (0.5) 
15 * 239 (95), 259 (91), 291sh (44), 328 (21), 360 (13), 374 (11), 416 (3.3) 
FIrpic - 277 (50), 301 (34), 304 (33) 337sh (14), 357sh (8.9), 400 (6.2), 454 (0.8)a 
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 Figure S155. Spectral data for rac 13. 
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Figure S156. Normalised emission spectra of complexes 7–12 in 2-MeTHF glasses at 77 K (λexc 355 nm). 
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Figure S157. Normalised emission spectra of complexes 13–15 in 2-MeTHF glasses at 77 K (λexc 355 nm). 
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